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Alzheimer’s disease (AD) is a progressive degenerative disorder that leads to cognitive and 
functional decline, various neuropsychological symptoms (NPS), and often early placement in
institutional care. The current options of prevention or pharmacological treatment of AD are very 
limited, and thus, interest in non-pharmacological approaches is growing. One of the most keenly 
studied subjects is physical exercise as a therapeutic strategy for persons with AD. Numerous 
studies have shown that physical exercise has a positive effect on cognition in healthy adults. 
However, findings in subjects with cognitive impairments are scarce and conflicting. 
This study, comprising four sub-studies, explores the effects of exercise on persons with cognitive 
impairment or dementia. Study 1, a systematic review, aims to explore the evidence from 
randomized controlled trials (RCTs) of cognitive benefits of exercise in people with mild cognitive 
impairment (MCI) or dementia. In Studies 2 and 4, an RCT investigates the effects of an exercise 
intervention on cognition, NPS, and rate of institutionalization in participants with AD compared 
with controls receiving treatment as usual. In addition, in Study 3 the effects of exercise on physical 
function and fall rate in persons with mild AD and persons with advanced AD are studied separately 
to determine whether the treatment effects differ at different stages of AD.
In Study 1, a systematic search of databases (PubMed, Cochrane, Dare, Ovid Nursing) was 
performed to identify RCTs reporting the effects of exercise interventions on cognition in MCI or 
dementia patients. Three independent investigators rated the relevant studies according to 
methodological quality and summarized the extracted data descriptively.  
FINALEX (Finnish Alzheimer Disease Exercise Trial) is an RCT (n=210) examining the effects of 
a 12-month exercise programme (60 minutes twice a week) in community-dwelling AD patients 
randomized into three study arms: home-based exercise (HE) (n=70), group-based exercise (GE) 
(n=70), and control group (CG) (n=70) without active intervention. The HE group exercised at their 
own homes supervised by a physiotherapist. The GE group trained in adult day-care centres in 
groups of ten supervised by two physiotherapists. 
Study 2 reports the effects on cognition. Cognitive function was measured using the Clock Drawing 
Test (CDT), Verbal Fluency (VF), Clinical Dementia Rating (CDR), and Mini-Mental State 
Examination (MMSE) at baseline and at 3, 6, and 12 months of follow-up.
In Study 3, the intervention groups were merged, and participants were re-grouped according to 




functioning (measured with the Functional Independence Measure, FIM) and fall rate were then 
explored separately in these groups. The incidence of falls was collected from fall diaries kept by 
each participant’s spousal caregiver.
Changes in NPS were examined after exercise intervention between the three original groups in 
Study 4.  NPS were assessed with the Neuropsychiatric Inventory (NPI) at baseline and at 6
months, and with the Cornell Scale for Depression in Dementia (CSDD) at baseline and at 12
months. Data on institutionalizations were retrieved from central registers.
For the systematic review, 22 trials meeting the inclusion criteria were found. The studies among 
older subjects with MCI reported some positive effects of physical exercise on cognition, mainly on 
global cognition, executive function, attention, and delayed recall. However, studies performed 
among older subjects with dementia showed inconsistent results. The studies had also various 
methodological problems.
In Study 2, home-based exercise was associated with a modest gain in executive function measured 
with the CDT compared with controls at 12 months (adjusted for age, sex, and CDR, p=0.03). No 
clear effects of the intervention on other measures of cognition (VF, MMSE) were found. Among 
participants with mild dementia (CDR ≤ 1), the deterioration in physical functioning was slower in 
the intervention group than in the controls. Changes in FIM at 12 months were -2.7 (95% CI -0.5 to 
-4.9) in the intervention group and -10.1 (95% CI -7.0 to -13.3) in the control group (p < 0.001). A
reduction in fall rate in participants with advanced dementia (CDR 2-3) was observed in the 
exercise group compared with controls during the 12-month follow-up, with an incidence rate ratio 
of 0.47 (95% CI 0.37-0.60; p < 0.001) (Study 3). No difference between the exercise and control 
groups was found in NPI score at 6 months or in CSDD score at 12 months when analyses were 
adjusted for age, sex, baseline CDR, and FIM. Furthermore, the exercise intervention did not reduce 
the rate of institutionalization among AD patients (Study 4).
Compliance with the exercise intervention in both groups was very good, and attrition rate was low. 
The exercise intervention was safe; no falls or major injuries occurred during the sessions. 
The current literature provides evidence that exercise interventions may have beneficial effects on 
cognition in persons with cognitive impairments. A 12-month regular, multicomponent, home-
based intervention improved executive function in AD patients. In addition, the exercise 
intervention showed a positive effect in slowing the rate of functional decline in mild AD and 
reducing falls in participants with advanced AD. However, the intervention did not decrease NPS or 





Alzheimerin tauti on etenevä degeneratiivinen tila, joka aiheuttaa kognitiivisen ja fyysisen 
toimintakyvyn heikentymistä sekä neuropsykiatrisia oireita. Alzheimerin tauti lisää myös riskiä
joutua pitkäaikaiseen laitoshoitoon. Alzheimerin tautiin ei ole tällä hetkellä ehkäisevää tai 
parantavaa lääkkeellistä hoitoa ja tästä syystä kiinnostus lääkkeettömiä hoitoja kohtaan onkin 
kasvanut. Liikunnan mahdollisuuksia Alzheimerin taudin ehkäisyssä ja hoidossa tutkitaan 
innokkaasti. Tutkimukset ovat osoittaneet, että liikunnalla on myönteisiä vaikutuksia terveiden 
ikääntyneiden kognitiivisiin toimintoihin. On mahdollista, että liikunnan avulla voidaan ylläpitää 
kognitiota ja toimintakykyä sekä vähentää neuropsykiatrisia oireita Alzheimerin tautia sairastavilla 
henkilöillä, mutta tutkimusnäyttö tästä on vielä varsin vähäistä ja ristiriitaista.
Tutkimus sisältää neljä osatyötä, joiden tarkoituksena on selvittää liikunnan vaikutuksia 
muistisairailla henkilöillä. Ensimmäisen osatyön (1) tavoitteena on selvittää tutkimusten tuottamaa 
näyttöä liikunnan vaikutuksista kognitioon henkilöillä, joilla oli todettu lievä kognitiivinen 
heikentymä sekä henkilöillä, joilla on muistisairaus.  Toisen ja neljännen osatyön tavoitteena on 
tutkia pitkäaikaisen liikuntaintervention vaikutuksia Alzheimerin tautia sairastavien henkilöiden 
kognitioon ja neuropsykiatrisiin oireisiin sekä laitoshoitoon joutumiseen. Kolmannen osatyön 
tavoite on selvittää liikuntaintervention vaikutuksia toimintakykyyn ja kaatumisten määrään lievää 
ja edennyttä Alzheimerin tautia sairastavilla.
Ensimmäinen osatyö on systemaattinen katsaus, jota varten tehtiin kirjallisuushaku käyttäen 
PubMed, Cochrane, Dare ja Ovid Nursing -tietokantoja. Katsaukseen hyväksyttyjen tutkimusten tuli 
olla satunnaistettuja, kontrolloituja tutkimuksia, jotka raportoivat liikuntaintervention vaikutuksia 
kognitioon lievästä kognitiivisesta heikentymisestä tai muistisairaudesta kärsivillä henkilöillä. 
Kolme tutkijaa arvioi tutkimusten metodologisen laadun ja tuloksia tarkasteltiin systemaattisesti. 
FINALEX (Finnish Alzheimer Disease Exercise Trial) on satunnaistettu, kontrolloitu tutkimus 
(n=210), jossa selvitettiin 12 kuukauden liikuntaintervention (60 minuuttia kahdesti viikossa) 
vaikutuksia kotona asuvilla Alzheimerin tautia sairastavilla. Tutkittavat jaettiin kolmeen ryhmään: 
kotiharjoittelijat (n=70), ryhmäharjoittelijat (n=70) sekä verrokkiryhmä (n=70), joka jatkoi 
tavanomaisessa hoidossa. Kotiharjoittelijat kuntoilivat omassa kodissaan fysioterapeutin ohjaamina, 
kun taas 10 hengen ryhmät harjoittelivat päivätoimintakeskuksissa kahden fysioterapeutin johdolla.   
Toinen osatyö kuvaa FINALEX-tutkimuksen liikuntaintervention vaikutuksia Alzheimerin tautia 




testillä (Mini-Mental State Examination) ja CDR -luokituksella (Clinical Dementia Rating) 
alkuvaiheessa, 3, 6 ja 12 kuukauden kohdalla. 
Kolmatta osatutkimusta varten kotiharjoittelijat ja ryhmäharjoittelijat yhdistettiin yhdeksi 
liikuntaryhmäksi ja osallistujat ryhmiteltiin uudelleen Alzheimerin taudin vaikeusasteen mukaan 
lievää ja edennyttä tautia sairastaviin. Tutkittavien fyysistä toimintakykyä arvioitiin FIM-mittarilla 
(Functional Independence Measure) ja kaatumisten määrää tarkasteltiin omaishoitajien pitämillä 
kaatumispäiväkirjoilla.
Neljännessä osatyössä verrattiin liikuntaintervention vaikutuksia neuropsykiatrisiin oireisiin ja 
laitoshoitoon joutumiseen kolmen alkuperäisen ryhmän välillä. Neuropsykiatrisia oireita arvioitiin 
alkuvaiheessa ja 6 kuukauden kohdalla käyttäen NPI-mittaria (Neuropsychiatric Inventory) ja 
alkuvaiheessa sekä 12 kuukauden kodalla käyttäen CSDD-mittaria (Cornell Scale for Depression in 
Dementia).    
Tiedonkeruu tuotti 22 tutkimuskriteerit täyttävää tutkimusta, jotka sisällytettiin systemaattiseen 
katsaukseen. Tutkimuksissa, joiden kohderyhmänä olivat lievää kognitiivista heikentymistä 
sairastavat iäkkäät henkilöt, todettiin positiivinen yhteys liikuntaharjoittelun ja kognition välillä. 
Tavallisimmin positiivisia vaikutuksia nähtiin kokonaisvaltaisesti kognitiota mittaavissa testeissä, 
toiminnanohjauksessa, tarkkaavaisuudessa ja viivästetyssä mieleen palautuksessa. Muistisairailla 
tutkimustulokset olivat ristiriitaisia ja tutkimuksissa todettiin metodologisia puutteita (Osatutkimus
1).
Pitkäaikainen kotiharjoittelu vaikutti positiivisesti tukittavien toiminnanohjaukseen (kellotesti) 12 
kuukauden kohdalla (vakioituna ikä, sukupuoli ja CDR-luokka, p=0.03). Muihin kognitiotesteihin 
(kielellinen sujuvuus, MMSE) harjoittelulla ei ollut tilastollisesti merkitsevää vaikutusta 
(Osatutkimus 2). Lievää Alzheimerin tautia (CDR ≤ 1) sairastavilla fyysisen toimintakyvyn 
heikentyminen oli merkitsevästi hitaampaa liikuntainterventioryhmässä kuin verrokkiryhmässä. 
FIM-pisteiden muutos 12 kuukauden kohdalla oli -2.7 (95% CI -0.5 to -4.9) liikuntaryhmässä ja -
10.1 (95% CI -7.0 to -13.3) verrokkiryhmässä (p < 0.001). Edennyttä Alzheimerin tautia (CDR 2-3)
sairastavien ryhmässä liikuntaharjoittelu vähensi merkittävästi kaatumisia verrokkeihin nähden 12 
kuukauden seurannassa. Ilmaantuvuustiheyksien suhde (IRR) oli 0.47 (95% CI 0.37-0.60; p <
0.001) (Osatutkimus 3). Liikunta – ja verrokkiryhmien välillä ei ollut merkitsevää eroa 
neuropsykiatrisissa oireissa mitattuna NPI-mittarilla 6 kuukauden kohdalla ja CSDD-mittarilla 12 




pisteiden suhteen. Liikuntainterventiolla ei myöskään ollut vaikutusta pitkäaikaiseen laitoshoitoon 
joutumiseen. 
Sitoutuneisuus liikuntaharjoitteluun oli erittäin hyvää molemmissa liikuntaryhmissä ja 
poisjättäytyneiden määrä oli pieni. Liikuntaharjoittelu oli turvallista eikä harjoitusten aikana 
tapahtunut kaatumisia tai muita vakavia onnettomuuksia.  
Tutkimusten mukaan liikunta vaikuttaa positiivisesti muistitoimintojen heikentymisestä kärsivien 
henkilöiden kognitioon. 12-kuukauden säännöllinen, monialainen, kotona tapahtuva 
liikuntaharjoittelu paransi Alzheimerin tautia sairastavien toiminnanohjausta. Lisäksi 
liikuntainterventio hidasti fyysisen toimintakyvyn heikentymistä lievää Alzheimerin tautia 
sairastavilla ja vähensi kaatumisia edennyttä tautia sairastavilla. Harjoittelu ei kuitenkaan 





The age-specific risk of Alzheimer's disease (AD) and other dementias in higher income countries 
has declined in the past 25 years. This decline is thought to be caused by increasing levels of 
education and improved control of cardiovascular risk factors (Matthews et al. 2013). However, the
total number of persons with AD and other dementias is expected to increase because of the 
population's shift to older ages (Alzheimer’s Association 2015). 
Today, dementia is among the leading causes of disability and death in the elderly, AD being the 
most common type of dementia in late life, and accounting for 50-70% of all dementia cases 
(Fratiglioni et al. 2000). AD is a neurodegenerative syndrome characterized by cognitive, 
functional, and psychiatric symptoms and leading to a decreased ability to perform activities of 
daily living and an increased need for support and care (Green et al. 2016). Since there is no cure 
for AD (Canter et al. 2016), the increase in the number of people with dementia will have a great 
impact on health and social care services.
Despite the lack of disease-modifying therapies for AD, research shows that active management of 
AD and other dementias can improve functional abilities, independence, and quality of life through 
all stages of the disease for affected persons, decreasing the burden of caregivers and society 
(Alzheimer’s Association 2015).
Physical activity promotes “active ageing”. Physical activity may reduce disability, improve quality 
of life, and preserve independence in older age (Crimmins et al. 2015). Epidemiological research
has also found a significantly reduced risk of developing dementia among physically active older 
adults (Ahlskog et al. 2011). Physical inactivity is the most important preventable risk factor for AD
(Matthews et al. 2013).
Exercise has been shown to have direct positive effects on the brain. It improves vascular health,
thereby enhancing cerebral perfusion and maintenance (Haskell et al. 2007). Exercise may also be 
influential in preserving neuronal structures and promoting neurogenesis and angiogenesis 
(Colcombe et al. 2003).
A growing body of scientific evidence indicates that exercise may be a potential non-
pharmacological treatment to alleviate symptoms of dementia or delay its progression 
(Lautenschlager et al. 2010).
Systematic reviews and meta-analyses evaluating the impact of exercise programmes on functional 




beneficial effects (Blankevoort et al. 2010, Littbrandt et al. 2011, Potter et al. 2011, Pitkälä et al. 
2013, Rao et al. 2014, Forbes et al. 2015). The evidence of the effects of exercise on cognitive 
functioning, neuropsychiatric symptoms (NPS), and fall rate is less clear (Forbes et al. 2015). There 
is also a need to clarify whether persons in various stages of dementia benefit from exercise 
interventions similarly and the optimal quality and quantity of exercise.
This study aims to systematically evaluate the evidence from RCTs of the effects of exercise on 
cognition in persons with MCI or dementia. In addition, it explores the effects of long-term exercise 
intervention on AD patients regarding cognition, NPS, and rate of institutionalization. Effects on 





2. Review of the literature
2.1 AD
2.1.1 Epidemiology and pathophysiology of AD and other dementias
Dementia is a clinical syndrome characterized by cognitive impairment, such as memory loss, and
impairment in executive function, skilled movements, language abilities, and neuropsychiatric 
features, causing significant decline from previous levels of functioning and reducing the capacity 
to perform usual activities (McKhann et al. 2011).
The World Alzheimer Report (2016) estimates that 46.8 million people worldwide were living with 
dementia in 2015, the annual incidence of new dementia cases being almost 10 million. The 
prevalence of dementia in people aged ≥ 60 years is 5-7% in most world regions (Prince et al. 
2013). In Finland, approximately 120 000 people are suffering from clinical memory disease and 
another 120 000 are living with MCI. The annual incidence of clinical memory disease is 13 000
(National Institute for Health and Welfare, Finland 2017).
Dementia is often preceded by MCI, which describes the cognitive state between normal cognitive 
ageing and dementia. The person is experiencing cognitive decline, but does not yet fulfil the
clinical criteria for dementia (Petersen et al. 1999). Some persons with MCI will progress to 
dementia, while others will remain stable or even show improvement. The presumed aetiology and 
the type of symptoms can be used to predict the type of dementia that the patient with MCI would 
most likely develop (Petersen et al. 2004).
Various neuropathologies may underlie dementia syndromes. AD is the most common type of
dementia in late life, accounting for 60-70% of all dementia cases (Alzheimer’s Association 2015).
Other types of dementia include vascular dementia, dementia with Lewy bodies (dementia in
Parkinson’s disease and Lewy body dementia), frontotemporal dementia, and alcohol-related brain 
damage (Dubois et al. 2007). In many cases, multiple brain pathologies are encountered, the most 
common combination being AD and vascular dementia (Schneider et al. 2007).
Disorders like thyroid disease, pernicious anaemia, hypercalcaemia, chronic infections of the 
nervous system, hydrocephalus, Huntington's disease, Creutzfeldt-Jakob disease, brain injuries, and 
tumours may also cause dementia, but are more rarely encountered (Dubois et al. 2007).
AD is a progressive neurodegenerative disorder causing dementia. The exact mechanisms and 




is thought to start the cascade in which amyloid plaques and neurofibrillary tangles are formed,
eventually leading to neuron death and brain atrophy (Aisen et al. 2017). Recent evidence indicates 
that amyloid-beta accumulation may not be the sole culprit, but additional factors, such as tau
pathology and synaptic, mitochondrial, metabolic, inflammatory, neuronal, cytoskeletal, myelin, 
and other age-related alterations, may also be involved in the pathogenesis of AD (De Strooper et 
al. 2016).
The first neuropathological changes in the brain can be seen years before the first clinical symptoms
of AD are detected (De Strooper et al. 2016). The state where only the molecular or imaging 
biomarkers are evident in cognitively healthy persons is called preclinical AD. Patients with 
preclinical AD may or may not have some subjective cognitive decline (Scheltens et al. 2016).
Prodromal AD or amnestic MCI is often a precursor to Alzheimer’s dementia. The annual rate of 
development of AD for patients with amnestic MCI is 10-15% (Tierney et al. 1996). AD can be
categorized into mild, moderate, and severe stages of illness where cognitive, functional, and 
neuropsychiatric difficulties and dependence on others progressively increase (Forstl et al. 1999).
2.1.2 Symptoms of AD
Cognitive symptoms of Alzheimer’s disease include progressive memory loss over years, with
simultaneous or later occurring impairments in other cognitive domains such as executive
functioning (e.g. planning and problem-solving), attention, communication (word-finding), or 
visuospatial abilities (agnosia, face recognition, and alexia) (Pena-Casanova et al. 2012). The 
cognitive symptoms are generally the earliest signs of AD, the most typical early complaints being
problems with episodic memory and the ability to learn and retain new information (Dubois et al.
2007). However, several non-cognitive symptoms may accompany all stages of the disease. These 
symptoms can be equally or even more devastating and burdensome for the patient and the
caregiver than the cognitive symptoms (Raudino et al. 2013).
Neuropsychiatric symptoms (NPS) are very common in AD patients, especially in the more
advanced stages, but may also be present years before clinical diagnosis. These symptoms include 
depression, apathy, wandering, aggression, agitation, disinhibition, delusions, hallucinations, and 
sleep and eating disturbances, among others. NPS are often difficult to manage, they cause an 
excessive burden on caregivers, and may lead to early nursing home placement (Kales et al. 2015).
AD is strongly related to frailty, sarcopenia, gait impairments, and weight loss, all of which increase 
the risk of falls and decrease physical performance and ADL abilities (Buchman et al. 2008, Burns 




years before cognitive impairment is clinically manifest (Bridenbaugh et al. 2014). In the advanced 
stage of AD, incontinence is frequent and basic motor skills, such as chewing and swallowing, may 
be impaired. Other motor disturbances, such as rigidity and primitive reflexes as well as 
extrapyramidal symptoms, myoclonus, and epileptic seizures, may occur at the very late stage of 
AD (Förstl et al. 1999).
After the clinical diagnosis of AD, life expectancy is significantly reduced. In a large longitudinal 
study in the US, the median survival from initial diagnosis was 4.2 years for men and 5.7 years for 
women (Larson et al. 2004). Lengthy duration of symptoms, severity of AD, old age, male sex, and 
physical disease are major risk factors for mortality in AD (Bowen et al. 1996). In addition,
decreased functional level, history of falls, findings of primitive reflexes, and abnormal gait are 
related to shorter life expectancy (Larson et al. 2004).
2.1.3 Risk factors and prevention of AD
The greatest risk factors for sporadic AD are age and family history with susceptible genes like the 
apolipoprotein E (APOE) ɛ4 gene. Those with the APOE ɛ4 form are more likely to develop AD at 
a younger age than those with the ɛ2 or ɛ3 forms of the gene (Corder et al. 1993). Researchers
estimate that up to 65% of people diagnosed with AD carry one or two copies of the APOE ɛ4 gene 
(Mayeux et al. 1998). Cases of familial AD make up 1-5% of patients with AD, and they are the 
result of disease-causing, autosomal dominant mutations in APP (amyloid-ß precursor protein) or 
mutations in PSEN1 (Presenilin-1), PSEN2 (Presenilin-2), and Trisomy-21(Canter et al. 2016).
In addition to the non-modifiable risk factors, several modifiable risk factors for AD have been 
identified. Poorly managed cardiovascular risk factors, such as diabetes, hypertension, 
hyperlipidaemia, smoking, sedentary behaviour, and obesity, especially in mid-life, are connected to 
cognitive decline and AD in later life (Baumgart et al. 2015).
Regular physical activity, particularly leisure-time activity, may reduce the risk of Alzheimer’s 
disease (Middleton et al. 2015, Iso-Markku et al. 2016, Santos-Lozano et al. 2016, Stephen et al. 
2017). Adherence to a Mediterranean-style diet is associated with slower rates of cognitive decline 
and reduced conversion to AD in MCI patients (Hardman et al. 2016). A healthy diet in mid-life 
seems to be protective of AD in later life (Eskelinen et al. 2011). People with more years of formal 
education have a lower risk for AD than those with fewer years (Baumgart et al. 2015). Some 
studies have also found cognitive training (Ball et al. 2002) and engagement in mental activities and 




al. 2015). Moderate and severe traumatic brain injuries may double or even quadruple the risk of 
developing Alzheimer's disease and other dementias (Plassman et al. 2000).
Alzheimer’s disease is a complex disorder with numerous risk factors, and it is likely that 
multifactorial interventions are needed for prevention (Deckers et al. 2015). The Finnish Geriatric 
Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) was a two-year 
multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring that
targeted older adults at risk for cognitive decline. The participants in the intervention group were 
able to improve or at least maintain their cognitive functioning (Ngandu et al. 2015).
2.1.4 Diagnosis of AD
The National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and 
The Alzheimer’s Disease and Related Disorders Association (ADRDA) criteria to diagnose AD are 
used in both clinical practice and research. These criteria were first devised in 1984 and then
revised in 2011. First, according to NINCDS-ADRDA criteria the patient must meet the criteria of 
dementia (as described above), and second, have progressive cognitive deficits typical to AD 
detected by history-taking from the patient and informant and objective cognitive assessments. 
Other causes of dementia must be excluded (Mc Khann et al. 2011). Perhaps the most widely used 
diagnostic criteria for AD in clinical work is the International Classification of Diseases, 10th
edition (ICD-10) (World Health Organization; 1990). The criteria of the Diagnostic and Statistical 
Manual of Mental Disorders, fifth edition (DSM-V) is commonly employed in mental health 
research (American Psychiatric Association 2013).
For diagnosis of AD, brain imaging and laboratory testing are required. Structural brain changes 
related to Alzheimer’s disease are visible on MRI and computed tomography (CT). The first 
changes are in the medial temporal lobe (including entorhinal cortex and hippocampus), and later 
also more general cortical atrophy is seen. With laboratory tests, the secondary causes of dementia,
such as hypothyroidism, hypercalcaemia, and B12 hypovitaminosis, can be excluded (Current Care 
Guidelines, Finland 2017).
When diagnosing AD in preclinical stages or when the clinical presentation is atypical, additional 
diagnostic measures are warranted. Cerebrospinal fluid shows changes in amyloid and tau levels.
Low amyloid β1–42 concentrations, increased total tau concentrations, or increased phospho-tau
concentrations, or combinations of the three suggest AD pathology (Olsson et al. 2016). Positron 
emission tomography (PET) or single photon emission computed tomography (SPECT) can be used 




(Frisoni et al. 2017). Definite diagnosis of AD can be made only when neuropathological 
examination demonstrates the presence of AD pathology in a patient with previously diagnosed 
clinical AD (McKhann et al. 2011).
2.1.5 Treatment of AD
Today, no disease-modifying treatment for AD is available (Canter et al. 2016). The 
pharmacological and non-pharmacological options are symptom-relieving at best. Donepezil, 
rivastigmine, and galantamine, together known as the cholinesterase inhibitors (ChEIs), act by 
increasing the amount of acetylcholine in the extracellular space, which is thought to promote 
neuronal activity and cholinergic signalling in the brain. The ChEIs have been found to be 
efficacious in improving cognitive functioning for patients with mild to moderate AD (Birks et al.
2006). Another drug approved for the treatment of AD is memantine, an NMDA (N-methyl-D-
aspartate) receptor antagonist affecting the glutamate metabolism and blocking the toxic effects of 
overactive glutamatergic activity. It is the only medical treatment approved in late-stage AD
(Areosa et al. 2005). Research in development of new therapeutic interventions for AD has been 
active in the last decades. However, the inability to find a definitive connection between clinical 
symptoms and changes in biomarkers complicates this task. While many large clinical drug and 
vaccine trials have reached phase 3, all have thus far failed to show positive results in clinical 
outcomes (Canter et al. 2016).
Until a pharmacological breakthrough occurs, the non-pharmacological treatment options have 
engaged the attention of researchers. The most consistent evidence is from multicomponent 
interventions based on caregiver education and support to delay institutionalization, improve quality 
of life (both patient and caregiver), and reduce the costs of care (Eloniemi-Sulkava et al. 2009, 
Groot et al. 2016). Relative to these, the effects on cognition, mood, and daily performance are 
smaller, but of the same magnitude as those of AD drugs (Groot et al. 2016). Similar but smaller 
effects have been obtained for cognitive stimulation (Woods et al. 2012), multicomponent 
interventions targeted at the patient, cognitive and ADL training, and behavioural interventions
(Olazaran et al. 2010). Regular, long-term exercise seems to improve physical functioning in 
participants with AD (Pitkala et al. 2013). Tailored nutritional guidance has also been found to 
enhance nutrition and quality of life and to prevent falls among community-dwelling individuals 




2.1.6 Cost and burden of AD to caregivers and society
AD is a life-changing issue for the patient and his/her family. Of persons with AD, 60-70% live in 
the community with most of the care provided by unpaid family carers (Lacey et al. 2013). In 
addition to the physical and emotional consequences to the patient, AD causes a burden on family 
carers, impairing their quality of life and health (Sörensen et al. 2011, Vernooij-Dassen et al. 2011). 
Family carers of dementia patients tend to have more health problems, visit health care 
professionals more often, suffer from isolation, and have an increased risk of depression and other 
illness than carers of people with other chronic illnesses (Vernooij-Dassen et al. 2011).
AD is also a major public health challenge, with a significant economic impact on health and social 
care services. The total estimated worldwide costs of dementia were US$ 604 billion in 2010. 
About 70% of the costs were incurred in western Europe and North America (Wimo et al. 2013). 
The economic burden of AD may even be underestimated since many indirect costs, such as 
adverse effects on care-givers’ health and productivity, are not invariably included in cost estimates
(Deb et al. 2017). Most of the costs come from institutional care and services, and only 1% come 
from disease diagnostics and medication (Current Care Guidelines, Finland 2017). AD costs 
increase with disease progression. The most significant association has been found between 
dependence of others (loss of functional abilities) and total care costs (Lacey et al. 2013).
2.2. Exercise and physical activity in dementia
To reduce the risk of cognitive decline in cognitively normal persons over 65 years of age, the 
World Health Organization (WHO) recommends a weekly minimum of 150 minutes of moderate-
intensity aerobic activity or 75 minutes of vigorous-intensity aerobic activity with additional 
muscle-strengthening exercises. According to the WHO, this would also apply to patients with 
neurodegenerative disease (WHO 2010).
Physical activity and exercise are terms that are often used interchangeably. However, physical 
activity is, by definition, any bodily movement produced by skeletal muscles and resulting in 
energy expenditure, whereas exercise is a subset of physical activity that is planned, structured, and 
repetitive (Caspersen et al. 1985).
Declining cognition brings changes to physical activity and abilities to exercise. Dementia patients’ 
physical activity levels are low compared with their healthy peers (Burns et al. 2008, Van Alphen et 




of falls, impaired physical performance (e.g. low gait speed), and day-time tiredness, have been 
found to be negatively associated with physical activity and participation in exercise (Stubbs et al. 
2014). Lower physical activity may also be the result of increasing problems with cognitive 
functions, especially with memory and executive functions (Van Alphen et al. 2016), and loss of
motivation and initiation, which are symptoms of apathy, a very common NPS across all stages of 
AD (David et al. 2012). Violations of autonomy, i.e. feelings of “being forced”, may also lower the 
motivation to physical activity (Stubbs et al. 2014). Similar to their healthy peers, some PWD may 
simply not like exercise and therefore need stronger motivators, support, and more tailored 
solutions than those who have a positive attitude towards exercise (Malthouse et al. 2014).
Difficulties in finding the way, fear of unknown places, and lack of support or transportation are 
reported as barriers to dementia patients’ exercise participation (Van Alphen et al. 2016).
Caregivers’ health, commitment, and attitude towards physical activity and exercise are important 
factors that also affect the physical activity level of PWD (Van Alphen et al. 2016). 
An exercise companion is important to facilitate participation and PWD benefit from specially 
designed exercise programmes that are carried out in small groups, offering peer support and
guidance by professionals (Malthouse et al. 2014). 
Although the overall benefits of exercise and physical activity are widely recognized also in PWD,
current recommendations by government guidelines, health authorities, and the World Health 
Organization are not specially directed to this patient group. According to studies, more specific 
recommendations from health care professionals and authorities would facilitate dementia patients’ 
participation in exercise and improve their level of physical activity (Van Alphen et al. 2016).
 
 2.3 Exercise and the brain
Regular physical activity throughout the lifespan has a strong association with better brain health
(Rovio et al. 2005, Middleton et al. 2010, Sofi et al. 2011, Iso-Markku et al. 2016).
The mechanisms by which physical exercise can affect the ageing brain are various at systemic, 
molecular, and cellular levels. Exercise has positive effects on brain structure and function, thus
creating resilience against the deteriorating effects of ageing and neurodegenerative diseases 
(Colcombe et al. 2003). Physical exercise lowers blood pressure and lipids and prevents metabolic 
syndrome (Haskell et al. 2007). It also improves cerebral circulation by increasing blood flow to the 
brain, thus improving oxygen supply and removing waste, and it has a restoring effect on 
endothelial function (Cotman et al. 2007). Regular exercise diminishes chronic inflammation, which 




of cerebrovascular disease (CVD) with regular exercise might be particularly important and 
effective for certain subgroups of people such as carriers of the APOE 4 allele (Schuit et al. 2001). 
The brain remains plastic throughout the lifetime. People with greater cardiovascular fitness tend to 
have larger cortical volume in the frontal, temporal, and parietal lobes as well as in the
hippocampus (Colcombe et al. 2003). Hippocampal atrophy is associated with memory impairment 
and dementia (Jack et al. 2004). Animal studies have revealed that exercise stimulates neuron 
proliferation in hippocampal areas, and exercise may even increase the volume of the hippocampus 
in humans (Erickson et al. 2011).  This increase is thought to be mediated by exercise-induced 
elevated levels of brain-derived neurotrophic factor (BDNF) (Erickson et al. 2011 Coelho et al. 
2013). Other growth factors, such as insulin-like growth factor-1 (IGF-1) and vascular endothelial 
growth factor, are also linked to exercise-induced neurogenesis and angiogenesis (Ratey et al.
2011).
Many neurodegenerative diseases, such as AD, have been linked to ageing-related defects in 
mitochondria. It is hypothesized that disturbances in mitochondrial maintenance and quality control 
may result in insufficient energy production or accumulation of misfolded proteins, e.g. β-amyloid 
(Marzetti et al. 2013). This harmful development can be slowed down with lifestyle changes such as
regular exercise (Lopez-Lluch et al. 2015).
Chronic stress can lead to dysfunction of the hypothalamic-pituitary-adrenal axis (HPA). This has 
been shown to decrease levels of BDNF and increase inflammation, oxidative damage, and 
amyloid-β peptides, which may lead to more rapid progression of cognitive decline (Csernansky et 
al. 2006). According to a longitudinal study of 200 older adults, women with the highest cortisol 
levels had the lowest cognitive test scores, and risk of cognitive decline increased when levels 
continued to rise during a 2.5-year follow-up (Seeman et al. 1997). In early stages of AD, patients’ 
cortisol levels are markedly elevated relative to those of their non-demented counterparts, and 
higher levels predict more rapid disease progression (Davis et al. 1986). Physically inactive persons 
tend to have more stress and higher cortisol responses to stress than persons who are physically 
active. It is well established that exercise can significantly relieve stress and related symptoms 




2.4 Effects of exercise in older adults with dementia
Scientific evidence of the effects of exercise on cognition, functional abilities, fall rate, and NPS in
PWD is discussed in the following sections. Results from epidemiological and intervention studies 
are reviewed. RCTs included in this literature review are put into a tabular form, and their main 
characteristics and findings are reported. The methodological quality of the RCTs is assessed with 
the criteria disclosed below. A summary of the quality assessment is shown in Table 5.
2.4.1 Methodological quality of randomized controlled studies discussed in the literature 
review and the review article (Study 1)
Methodological quality of the studies included in the literature review and in the systematic review 
(Study 1) was assessed by using a modified rating system applying the criteria for randomized 
intervention trials used by Cochrane and collaborators (Higgins et al. 2011), the PEDro scale, a tool 
for measuring the methodological quality of clinical trials related to physiotherapy interventions
(Maher et al. 2003), and criteria developed by the Evidence-Based Medicine Working group 
(Guyatt et al.1993, Guyatt et al. 1994). An additional criterion involving compliance was 
incorporated since compliance is often low in exercise studies. The 13 criteria are described in
detail below. Each criterion is equivalent to 1 point. The quality of the research study is considered 
high with a score of 11-13 points, moderate with a score of 7-10 points, and poor with a score of <7 
points.
1. The diagnosis of dementia is based on the DSM-IV (American Psychiatric Association 2013) or
NINCDS-ADRDA criteria (McKhann et al. 2011) or is made by a geriatrician, a neurologist, or an 
old age psychiatrist.
2. Inclusion and exclusion criteria are satisfactorily described.
3. The intervention is described in sufficient detail.
4. The measurements and outcome measures are valid and adequately defined.
5. The study has sufficient statistical power to detect an effect (n ≥ 25/group).
6. The randomization method is adequately described, and the method is valid (a computerized 
randomization programme or a separate randomization centre).
7. The group assignment is blinded when assessing the outcomes.




9. Groups are comparable at baseline regarding the most important indicators.
10. The drop-outs are described, and the analyses take them into account.
11. The compliance of participants is described.
12. Complications are reported.
13. A comparison is made in relation to outcome variables between the groups.
2.4.2 Effects of exercise on cognition in older adults with dementia 
Physical activity has biological effects on brain functions and vascular risk factors, and thus, there 
is a direct link between cognition and exercise (Colcombe et al. 2003). Epidemiological studies 
have shown that increased engagement in lifetime physical activities reduces the risk of cognitive 
decline and dementia in older age (Hamer et al. 2009, Geda et al. 2010, Middleton et al. 2010,
Buchman et al. 2012, Lee et al. 2015, Llamas-Velasco et al. 2015, Iso-Markku et al. 2016). 
However, systematic reviews and meta-analyses of RCTs examining the effects of exercise 
interventions on cognition among cognitively healthy older adults have found the evidence to be 
somewhat insufficient and conflicting (Colcombe et al. 2003, Angevaren et al. 2008, Smith et al.
2010, Snowden et al. 2011, Kelly et al. 2014, Young et al. 2015).  Some meta-analyses suggest 
beneficial effects especially in executive function (Colcombe et al. 2003, Angevaren et al. 2008,
Smith et al. 2010), yet, the more recent meta-analyses with larger data contradict these findings 
(Snowden et al. 2011, Kelly et al. 2014, Young et al. 2015). Differences have been described in
participant profiles, study design, exercise programmes, adherence rates, and outcome measures 
across studies. 
Interestingly, meta-analyses of RCTs performed among participants with MCI are rather consistent,
revealing positive intervention effects (van Uffelen et al. 2008, Wang et al. 2014, Zheng et al.
2016). Nevertheless, the authors have suggested cautious interpretation of their results because of 
the methodological limitations of the incorporated RCTs and the small effect sizes diminishing the 
clinical value of the results (van Uffelen et al. 2008, Wang et al. 2014, Zheng et al. 2016).
The Cochrane review from 2015 found 17 RCTs examining the effects of exercise in dementia 
patients; of these, 9 RCTs (n=499) had outcomes related to cognition. The studies were relatively 
small, from 18 to 97 participants, and most were conducted in nursing homes.  The review revealed 
no clear evidence of benefits of exercise intervention on cognition in PWD. However, the authors 




exercise intervention, and methodological shortcomings may attenuate the overall results (Forbes et 
al. 2015). Groot and co-workers conducted meta-analyses of RCTs examining the effects of 
physical activity on cognitive function in dementia patients. They incorporated 18 relevant studies,
with altogether 802 participants with dementia, into the meta-analyses. They found a positive effect 
of exercise on cognitive functions in dementia patients. The effect was driven by interventions 
including aerobic exercise, and was independent of the type of dementia. Yet, the authors 
emphasize that methodological limitations exist and larger studies of better methodological quality 
to examine the effects of exercise on cognition in PWD are warranted (Groot et al. 2016).
Since the forementioned meta-analyses, many new studies have been published. A database search 
(Medline, Ovid, PsycINFO, Cochrane Database) in September 2017 produced 25 RCTs (n=1781) 
examining the cognitive effects of exercise in PWD. The studies are shown in Table 1. Eleven 
studies were conducted in community settings (Burgener et al. 2008, Kwak et al. 2008, Miu et al. 
2008, Steinberg et al. 2009, Vreugdenhil et al. 2011, Yaguez et al. 2011, Arcoverde et al. 2014, 
Holthoff et al. 2015, Hoffman et al. 2016, Dawson et al. 2017, Morris et al. 2017) and 14 in nursing
homes (Friedman et al. 1991, Cott et al. 2002, van de Winckel et al. 2004, Stevens et al. 2006,  
Christofoletti et al. 2008, Hokkanen et al. 2008, Eggermont et al. 2009, Kemoun et al. 2010, 
Venturelli et al. 2011, Cheng et al. 2014, Bossers et al. 2015, Telenius et al. 2015, Cancela et al. 
2016, Toots et al. 2017). In addition to the setting, the studies varied considerably in number of 
participants (range 20 to 200), severity of participants’ cognitive impairment, type, intensity, and 
duration of exercise programmes, and whether or not an active control group was employed.  Of the 
25 studies, nine included only patients with Alzheimer’s dementia (Friedman et al. 1991, Cott et al. 
2002, Steinberg et al. 2009, Kemoun et al. 2010, Venturelli et al. 2011, Vreugdenhil et al. 2011, 
Yaguez et al. 2011, Holthoff et al. 2015, Hoffman et al. 2016), while the other study populations 
comprised patients with various types of dementia such as vascular dementia, Parkinson’s dementia, 
frontotemporal dementia, mixed dementia, and dementia of unknown cause. This may further 
weaken the comparability of the studies, as cognitive functions may not be equally affected in 
different subtypes of dementia, and there is a substantial variation also in the trajectories of the 
cognitive symptoms (Oosterman et al. 2006, Ingles et al. 2007, Kandiah et al. 2009, Smits et al. 
2015).
Three small studies among community-dwelling AD patients found positive effects after an exercise 
intervention: one study in global cognition measured with MMSE and ADAS-Cog (Vreugdenhill et 
al. 2011) and the others in executive function (Yaguez et al. 2011, Holthoff et al. 2015,) and in 




mild AD in a community setting failed to show positive effects after 16 weeks of moderate to high 
intensity exercise. However, among those who adhered to the protocol there was a significant 
change in the Symbol Digit test in favour of exercise (Hoffmann et al. 2016).
Two studies conducted in communal settings that included patients with various types of dementia 
were able to show improvement in MMSE after fairly long exercise interventions of 40 weeks 
(Burgener et al. 2008) and 52 weeks (Kwak et al. 2008). In two studies with shorter interventions,
no effects were detected (Miu et al. 2008, Steinberg et al. 2009).
Studies conducted in nursing home settings included higher numbers of participants, were on 
average more intensive and longer in duration, and involved patients in more advanced stages of
dementia than those conducted among community-dwellers.  The results were mixed.
MMSE and memory improved relative to the control group (recreational activities) after daily 
indoor cycling for 15 months in a large Spanish study with 189 moderately demented participants in 
nursing homes (Cancela et al. 2016).  In an Italian study, global cognition (measured with MMSE) 
remained stable during a 16-week walking intervention, while participants receiving usual care 
deteriorated (Venturelli et al. 2011). Walking and balance exercises three times a week for 15 
weeks improved participants’ performance in a multidomain cognitive test battery consisting of 
tests for executive function and memory (Kemoun et al. 2010). Improvements in communication 
skills were found after 10 weeks of walking and conversation sessions in severely demented 
participants (Friedman et al. 1991). Cheng and co-workers randomized 110 participants to an 
exercise intervention of Tai Chi three times a week for three months or to two control activity 
groups (Mahjong card game or handicrafts). Those practising either Tai Chi or Mahjong improved 
in MMSE and Digit Span forward. The intervention effect was preserved as time progressed, and by 
nine months the Tai Chi group differed from the handicrafts group by a mean improvement of 3.7
points in MMSE (Cheng et al. 2014).
Twelve weeks of strength and balance exercises did not change MMSE scores in nursing home 
patients with moderate dementia. However, the primary outcomes of the study were balance and 
functional mobility, and the exercise programme was not designed to improve cognition (Telenius
et al. 2015). Another fairly large and good-quality study showed no improvement in memory or 
executive function test after six weeks of a walking programme. The researchers discuss that the 
lack of beneficial effects could be due to the high number of co-morbidities in the study population 




methodological quality with 186 participants failed to show positive results in cognitive outcomes 
after 16 weeks of high-intensity exercise twice or thrice a week (Toots et al. 2017).
Morris and co-workers found evidence that improvements in cardiorespiratory fitness after 26 
weeks of aerobic exercise intervention were related to brain volume change visible in MRI, yet they 
were unable to show positive changes in cognitive tests (Morris et al. 2017). As known from the 
previous research, an observation of structural changes in the brain may not necessarily equal 
corresponding effects on cognitive function (Erickson et al. 2011).
Whether exercise improves cognition in PWD remains unknown.  The results from the RCTs are 
mixed, and the clinical significance of the positive results is unclear.
The neurocognitive tests used across studies are numerous and heterogeneous. This finding is 
consistent with the results of a recent article on neuropsychological tests used in studies 
investigating treatment effects on cognition in dementia patients (Bossers et al. 2012, Concalves et 
al. 2018). Tests measuring global cognition were more frequently used than tests covering a single 
cognitive domain. Global cognition was generally measured with MMSE, which has good 
reliability but may be insensitive to change (Tombaugh et al. 1992, Mulligan et al. 1996,). It may 
also be questioned whether any changes in global cognitive measures can be seen in a period as 
short as three or four months.      
On the basis of the studies in Table 1, the key elements in an exercise intervention to improve 
cognition in dementia patients appear to be long duration (Burgener et al 2008, Christofoletti et al. 
2008, Kwak et al. 2008, Vreugdenhil et al. 2011, Cancela et al. 2016), high intensity (van de 
Winckel et al. 2004, Burgener et al. 2008, Christofoletti et al. 2008, Kemoun et al. 2010, Venturelli 
et al. 2011, Vreugdenhil et al. 2011, Cheng et al. 2014, Bossers et al. 2015, Holthoff et al. 2015,
Cancela et al. 2016) and aerobic exercise (Friedman et al. 1991, Arcoverde et al. 2014, Bossers et 
al. 2015, Holthoff et al. 2015, Cancela et al. 2016, ). Conducting such studies can be difficult 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.4.3 Effects of exercise on mobility and functional abilities in older adults with dementia
Deterioration of day-to-day functional abilities is a major feature of AD and other dementias,
eventually leading to disability and loss of independence. This process begins already in the early 
stages of dementia and proceeds with the decline in cognition (Tschanz et al. 2011). Impaired 
muscle strength, mobility, and balance are known symptoms of dementia and are associated with 
difficulty in performing the basic activities of daily living (Roach et al. 2011). Co-morbidities and 
environmental factors are also important elements defining the course of functional decline 
(Haaksma et al. 2017).
In longitudinal studies, the rate of decline in daily performance has been found to be an even more 
predictive factor of early nursing home placement than cognitive deterioration (Wattmo et al. 2011). 
ADL abilities are also considered a key factor in the quality of life of people with dementia 
(Rolland et al. 2007). According to the European Task Force Group, assessment of the functional 
abilities in PWD is highly relevant in research as well as in a clinical context (Vellas et al. 2008).
Non-pharmacological therapies, such as caregiver education, occupational therapy, and exercise, 
can improve functioning in daily activities among dementia patients and postpone 
institutionalization (Olazaran et al.2010, Littbrand et al. 2011, McLaren et al. 2013). Benefits of 
active interventions can be achieved even in nursing home patients with advanced dementia 
(Luttenberger et al. 2012). Effects of exercise to improve mobility and functional abilities in PWD
have been investigated in numerous studies. Systematic reviews and meta-analyses evaluating 
results of these studies appear to have reached similar conclusions regarding the beneficial effects 
of exercise. There seems to be no difference whether all kinds of studies (Blankevoort et al. 2010, 
Potter et al. 2011, Rao et al. 2014) or solely RCTs (Littbrand et al. 2011, Pitkälä et al. 2013) are
included in the analyses.  
A database search (Medline, Ovid, PsycINFO, Cochrane Database) in September 2017 produced 28
RCTs exploring exercise as a single intervention to improve or stabilize functional abilities and 
mobility in dementia. Descriptions and main outcomes of the studies are shown in Table 2. Nursing
home residents with dementia have been assessed in 12 (Tappen et al. 2000, Cott et al. 2002, 
Toulotte et al. 2003, Stevens et al. 2006, Rolland et al. 2007, Christofoletti et al. 2008, Kemoun et 
al. 2010, Roach et al. 2011, Venturelli et al. 2011, Telenius et al. 2015, Cancela et al. 2016, Toots et 
al. 2016, ) and community-dwellers in 16 of the studies (Pomeroy et al. 1999, Teri et al. 2003, 
Burgener et al. 2008, Kwak et al. 2008, Miu et al. 2008, Steinberg et al. 2009, Vreugdenhil et al. 




et al. 2014, Holthof et al. 2015, Hoffman et al. 2016, Dawson et al. 2017, Morris et al. 2017).
Despite large heterogeneity of the study populations, stage of dementia, study settings, exercise 
interventions, and methodologies, 23 (n=1804) out of the 28 studies examining the effects of 
exercise on functional abilities, mobility, and physical functioning found positive effects (Tappen et 
al. 2000, Teri et al. 2003, Toulotte et al. 2003, Stevens et al. 2006, Rolland et al. 2007,
Christofoletti et al. 2008, Kwak et al. 2008, Miu et al. 2008, Steinberg et al. 2009, Kemoun et al. 
2010, Roach et al. 2011, Venturelli et al. 2011, Vreugdenhil et al. 2011, Pitkälä et al. 2013,
Suttanon et al. 2013, Arcoverde et al. 2014, Hauer et al. 2014, Schwenk et al. 2014, Holthof et al. 
2015, Telenius et al. 2015, Cancela et al. 2016, Toots et al. 2016, Morris et al. 2017).
Positive results were associated with intensive multicomponent exercise and interventions lasting at 
least 12 weeks (Table 2). Studies without positive results were conducted either among severely 
demented nursing home patients (Cott et al. 2002) or the duration of the exercise intervention was 
very short (Pomeroy et al. 1999).
In 13 of the studies with positive results, the primary outcomes were physical measurements such 
as walking abilities, muscle strength, balance, and flexibility.  The most frequently utilized 
measures were 2/4/6-minute walking distance, 4/10-m walking speed, Timed up and go (Mathias et 
al. 1986), leg press repetitions, Berg Balance Score (Berg et al. 1992), and Functional Reach
(Duncan et al. 1992).
Although decreased balance and gait improvements have been associated with lower ADL function 
in dementia (Mazoteras-Munoz et al. 2010), these may be regarded as surrogate variables, and a 
direct extrapolation to improvements of actual functional abilities cannot be justified.  Surprisingly,
even in studies examining the effects of exercise on balance, only one study reported positive 
changes in fall risk related to improvement of balance after the intervention (Suttanon et al. 2013).
Assessments of functional abilities measured with multifaceted instruments (Katz-ADL (Katz et al. 
1963), Barthel-ADL (Mahoney et al. 1965), Lawton-IADL (Lawton et al. 1969), FIM (Pollak et al. 
1996), SF-36 (Hayes et al. 1995)) were performed in 12 studies. Eleven of these studies achieved 
positive results (Table 2). Long duration of the exercise intervention (12-52 weeks) and progressive 
increase in exercise intensity appeared to be decisive factors for success. Music was used in some 
successful studies during the exercise sessions to create a positive atmosphere and enhance 
adherence (Rolland et al. 2007).
Participants with non-Alzheimer’s dementia benefitted from exercise intervention more than those 




were thought to result from lower baseline cognition in AD patients, but also differences in motor 
skill learning abilities, as memory impairment is often more pronounced in AD patients than their 
non-AD counterparts (Toots et al. 2016). One large, good-quality study did not find improvements 
in ADL performance after 16 weeks of moderately intensive training. The authors discussed that the 
negative finding may have resulted from a ceiling effect, as the participants had mild AD with 
rather high baseline functioning (Hoffmann et al. 2016).  This is supported by the finding that low
baseline motor functioning predicted the most positive training response in participants with mild 
dementia after 12 weeks of resistance and functional training (Schwenk et al. 2010). Roach and co-
workers also observed that participants with the lowest mobility at baseline showed the largest 
improvement in mobility scores after 16 weeks of multicomponent exercise training (Roach et al.
2011).
Exercise adherence was found to be a significant predictor of positive results in many studies 
(Rolland et al. 2007, Hauer et al. 2012, Telenius et al. 2015, Cancela et al. 2016). Especially 
concerning the effects of exercise on muscle strength, there appears to be a dose-response 
relationship, and it seems to require more effort to improve muscle strength than balance (Telenius
et al. 2015).
Active control was employed in 13 of the 28 studies. Often the controls were offered social 
activities (Pomeroy et al. 1999, Tappen et al. 2000, Stevens et al. 2006, Roach et al. 2011, Telenius 
et al. 2015, Cancela et al. 2016, Toots et al. 2016), but low-intensity exercise such as stretching was 
also used (Hauer et al. 2012, Morris et al. 2017, Schwenk et al. 2014). The results appeared not to 
be dependent on whether the control group was active or continued normal care. 
Sustainability of the effects of the exercise interventions on functional abilities has only been
explored in a few studies (Teri et al. 2003, Miu et al. 2008, Hauer et al. 2012, Telenius et al. 2015, 
Hoffmann et al. 2016, Toots et al. 2016). In a German study among community-dwelling 
participants with mild dementia, the positive effects of 12 weeks of resistance and functional 
training were still detectable in walking abilities, balance and muscle strength at a three-month 
follow-up (Hauer et al. 2012). Similar results were obtained in nursing home residents with more 
advanced dementia (Telenius et al. 2015, Toots et al. 2016), although the Swedish study found 
sustainability in balance predominantly in those participants with better cognition at baseline (Toots
et al. 2016). The effects of an exercise and behavioural management intervention were sustained in
functional abilities measured with the SF-36 instrument at a 24-month follow-up in a community 
setting among participants with moderate AD (Teri et al. 2003). In a small study among patients 




performance during the 12-week study period and the 12-week follow-up, whereas the controls 
experienced a considerable decrease in performance (Holthoff et al. 2014).
The evidence supporting positive effects of exercise on functional abilities and mobility in PWD 
appears to be rather convincing. However, physical performance as represented in activities of daily 
living is multifactorial, with numerous factors and causes that may not be equally susceptible to 
changes. Therefore, better balance after exercise intervention may improve overall scores of ADL 
performance, but the effects on, for instance, urinary incontinence may be less pronounced. ADL 
abilities are associated strongly also with the level of cognition, especially executive functions, and 
it is safe to assume that interventions benefitting both physical functions and cognition would be the 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.4.4 Effects of exercise on fall rate in older adults with dementia
A fall is an unexpected event whereby a person involuntarily comes to lie on the ground or another 
lower level with or without loss of consciousness (Lamb et al. 2005).
Falls are a common cause of morbidity, permanent functional decline, and mortality in people with 
dementia. The annual incidence of falls in this patient group is estimated to be as high as 70-80% 
(Shaw et al. 2007). These patients are also at higher risk of fall-associated major injuries such as 
fractures or head trauma (Meuleners et al. 2017). Furthermore, PWD are at greater risk of a hospital 
admission for an injury (Meuleners et al. 2017), and after an injurious fall at risk of early nursing
home placement (Tinetti et al. 1997). PWD fall more often than their cognitively healthy peers 
(Allan et al. 2009, Taylor et al. 2013). This is seen in all subtypes of dementia, the patients with 
Parkinson dementia and dementia with Lewy bodies being at the highest risk (Allan et al. 2009).
The higher fall risk in PWD may result from various factors. Most of the common risk factors, such 
as increasing age, decline in balance and muscle strength, impaired vision, history of falls, 
multimorbidity, and polypharmacy, are shared with cognitively intact older people, but have a
higher prevalence and greater severity in PWD (Shaw et al. 2007). Malnutrition or undernutrition is 
common in PWD (White et al. 1998, Volkert et al. 2015) and can lead to involuntary weight loss, 
sarcopenia, and frailty, resulting in increased fall risk (Evans et al. 1993).
Decline in cognition has a strong association with deterioration in gait parameters (Allali et al. 
2016). Walking is to some extent an automatic task, but it also requires higher cortical functions, 
especially executive functions, and attention (LaJoie et al.1993). In older age, part of the 
automaticity of walking is lost due to physical changes in the body, e.g. sensory deficits and decline 
in muscle strength (Skelton et al. 1994). To overcome these physical handicaps, an older person
needs to rely more on executive functions for safe walking than his younger peers. In persons with 
dementia, the cognitive resources may not be high enough to ensure safe walking, especially while
dual-tasking, and the risk of falling increases (Bridenbaugh et al. 2015). Decline in MMSE score in 
PWD (Gleason et al. 2009) or poor executive function in older adults (Kearney et al. 2013) seem to 
indicate an increased risk for falling, supporting the forementioned theory. 
In prospective studies, depression, orthostatic hypotension, use of cardioactive or psychotropic 
medication, low physical activity, and previous falls have been found to predict increased fall rate 
in PWD (Allan et al. 2009, McDonald et al. 2016). Central autonomic dysfunction seen frequently 
in PWD may contribute to the increased risk of orthostatic hypotension in addition to medication 




Recurrent falls may lead to fear of falling, causing reduced activity and ultimately loss of muscle 
strength, balance, and mobility. Injurious falls often lead to hospitalization and may eventually 
increase the risk of permanent nursing home placement (Shaw et al. 2007).
Preventive interventions that target falls are more likely to be effective in participants with normal 
cognition or with only minor cognitive problems (Montero-Odasso et al. 2012). Assessing
environmental hazards, using assistive and protective (technological) aids, staff education, and 
vision assessment/correction seem to reduce the falls in older adults living in communal settings
(American Geriatric Society guideline 2011, Rimland et al. 2016). Vitamin D and calcium 
supplementation may also be beneficial (American Geriatric Society guideline 2011).
According to the meta-analyses, the single-component non-pharmacological intervention with the 
most positive impact on fall prevention has been exercise. Exercise reduces the number of falls in 
older adults without cognitive decline (Gillespie et al. 2012), especially in those living in the 
community (Rimland et al. 2016). Exercise programmes seem to be effective also in preventing 
injurious falls in older adults (El-Khoury et al. 2013). Effective exercise programmes frequently 
comprise a combination of low-extremity strength training and balance exercises that are 
progressive in intensity (Rimland et al. 2016).
The most consistently effective intervention among various settings appears to be multifactorial and
tailored to tackle individually assessed risk factors. Exercise has frequently been part of the 
multifactorial interventions (Rimland et al. 2016).
While it might be tempting to extrapolate earlier evidence to PWD, it is not an appropriate
approach, as the underlying mechanisms for risk factors for falls may be various (Jensen et al. 2003,
Guo et al. 2013, Meuleners et al. 2017). PWD are generally frailer and clinically more unstable than 
cognitively healthy older adults (Oliver et al. 2007). Results from fall prevention studies among 
PWD are conflicting or inconclusive generally due to methodological problems and/or small 
number of participants (Shaw et al. 2007, Am Ger Soc 2011) According to the American Geriatric 
Society Clinical Practice Guideline, there is insufficient evidence supporting any recommendations 
to reduce fall risk in older persons with cognitive impairment (Am Ger Soc 2011). A systematic 
review exploring the results of 43 studies among PWD reporting rate of falls in hospital or care 
home settings found that multifactorial interventions (including e.g. risk factor assessment, care 
planning, medical/diagnostic approaches, changes in physical environment, education programmes, 
medication review, hip protectors, removal of physical restraints, and exercise) seem to prevent falls 




physical restraints, fall alarm devices, calcium/vitamin D, exercise, changes in physical 
environment, or medication review) in care homes or hospital settings showed no significant effect 
on falls (Oliver et al. 2007).
Studies addressing the effects of exercise as a single intervention on fall rate in dementia patients 
are scarce, albeit some good-quality RCTs (Pitkälä et al. 2013, Suttanon et al. 2013, Zieschang et al. 
2017) and even systematic reviews exist (Chan et al. 2014, Burton et al. 2015).
In a recent systematic review investigating the effectiveness of exercise interventions in reducing 
falls in PWD, the authors were able to incorporate data from only seven relevant RCTs involving 
781 participants (Chan et al. 2014). Four of the seven studies showed a significant effect in reducing 
the fall rate. The studies were heterogeneous in their setting (nursing home residents or community-
dwellers) and the duration and intensity of the intervention, diminishing the generalizability of the 
results. According to the authors, the core elements of a successful intervention were 
multicomponent exercise (combination of strength, endurance, and balance training), supervision of 
the training by a professional trainer, and an individually tailored exercise programme adapted to 
the cognitive level of the participant (Chan et al. 2014).  Another systematic review including four 
exercise intervention studies (n=243) conducted among community-dwelling PWD achieved similar 
results. The studies included in the review were of good methodological quality with sufficient 
statistical power (Burton et al. 2015). Authors of both reviews state that further research with 
studies using standardized outcomes, larger sample sizes, and longer follow-up periods is needed 
(Chan et al. 2014, Burton et al. 2015).
The number of dementia patients is growing fast, meaning more falls and increasing health care and 
economic burden (Davis et al. 2010). Cost-effective prevention programmes and novel models of 
intervention are warranted. Despite the small body of research so far, exercise has reasonably solid 
evidence of efficacy in reducing fall risk in PWD.  Falls in PWD are likely of multifactorial origin,
requiring multifactorial preventive measures, and exercise should be part of these programmes.
Technology and digitalization are starting to be essential also in the lives of PWD, and new 
solutions for fall prevention, e.g. virtual exercise and balance training, or monitoring changes in 
patient’s movements or vital signs, are already available. Sensor-derived physical activity 
parameters are independent predictors of fall risk and may have higher diagnostic accuracy in 
persons with dementia compared with conventional fall risk measures (Schwenk et al. 2014).
However, only a few studies of these technology-assisted methods have been published to date (van 


















































































































































   
   
   





















































































































































































































































































































































































































































































































































































































































































































































































































































2.4.5 Effects of exercise on neuropsychiatric symptoms in older adults with dementia
Neuropsychiatric symptoms in dementia is an umbrella term that covers several behavioural and 
psychological symptoms, such as agitation, depression, apathy, delusions, hallucinations, aberrant 
motor behaviour, disinhibition, irritability, euphoria, eating problems, and sleep impairment,
occurring alone or in clusters of symptoms (Lyketsos et al. 2002, Aalten et al. 2007). These clusters 
of symptoms or subsyndromes may differ in prevalence, course over time, or pathophysiology 
(Robert et al. 2005, Aalten et al. 2007). Although minor differences in the studies exist, definitions 
of the subsyndromes of hyperactivity, mood, and psychosis are in general agreement and supported 
by clinical evidence (Levy et al. 1996, Robert et al. 2005, Aalten et al. 2007). Treatment 
interventions are considered to be more beneficial when targeting subsyndromes rather than 
individual symptoms (Aalten et al. 2007, Dechamps et al. 2008).
Multiple factors may contribute to NPS; they can be related to the patient, to the caregiver, or to the
environment (Kales et al. 2015). Neuroscientific studies have revealed direct links between 
disrupted neuronal circuits, changes in neurotransmitter and synaptic function in brain areas 
associated with behaviour or emotion, and certain neuropsychiatric symptoms of dementia (Geda et 
al. 2013) Acute illness or discomfort, inability to express or satisfy needs, and patients’ pre-existing 
psychiatric or personality problems may be factors leading to NPS (Kales et al. 2015). Providing 
care for a person with dementia is a risk for the caregiver’s psychological well-being, especially 
when the care recipient is suffering from NPS (Pinquart et al. 2003). Moreover, caregiver stress and 
burden may elicit or aggravate NPS in the dementia patient and impede treatment strategies. Ability 
to cope with external or internal stressors is often decreased in PWD; change in daily routines, too 
much or a lack of stimuli, or tasks exceeding functional capacity may induce stress, leading to NPS
(Kales et al. 2015).
The majority of PWD suffer from NPS over the course of the disease (Lyketsos et al. 2002, Aalten
et al. 2005, Gonfrier et al. 2012). In the longitudinal Cache County Study, 75% of PWD exhibited 
one or several NPS over an 18-month period (Lyketsos et al. 2002), whereas in the Maasbed study 
the prevalence of NPS was as high as 95% in the two-year follow-up (Aalten et al. 2005). Separate 
NPS have their own specific prevalence and course over time, but overall, neuropsychiatric 
symptoms tend to be present chronically (Aalten et al. 2005). The course of the NPS can be 
persistent or intermittent, the frequency of the symptoms increasing with disease severity (Brodaty 
et al. 2015). The most persistent and frequent NPS seem to be apathy and aberrant motor 




symptoms best predicting early placement in permanent nursing home care seem to be aggression, 
hallucinations, and depression (Gilley et al. 2004).
NPS are associated with faster decline in daily performance and cognition, lower quality of life for 
the patient and the caregiver, and early institutionalization and higher public health costs (Lyketsos 
et al. 2002, Gilley et al. 2004).
Traditionally, pharmacological treatment has been used to relieve the NPS. Cholinesterase 
inhibitors (donepezil, galantamine, and rivastigmine) may improve neuropsychiatric symptoms in 
AD patients and are recommended as a first-line pharmacological therapeutic option (Rodda et al. 
2009, Wang et al. 2015). The various cholinesterase inhibitors appear equal in efficacy (Trinh et al. 
2003). For memantine, the results are conflicting, although some RCTs have found beneficial 
treatment effects, especially on agitation and irritability (Gauthier et al. 2010, Kales et al. 2015).
Atypical antipsychotics have the strongest evidence base when treating NPS in PWD. However, the 
treatment effects are modest, the effect size being 0.13-0.16, and mainly seen in reducing aggressive 
behaviour (Kales et al. 2015).  Moreover, serious adverse effects, such as parkinsonism and 
cerebrovascular events, that are frequently seen in AD patients treated with antipsychotics, may 
outweigh the minor benefits (Schneider et al. 2005). The increased risk of cerebrovascular event is 
considered a class effect for all antipsychotics (Kales 2015). The only antipsychotic medicine 
approved by the European Medicine Agency for NPS is risperidone, but off-label use of other 
antipsychotics is frequent (EMA 2008).
Antidepressants may have positive effects on depressive symptoms and agitation in dementia,
although results of recent meta-analyses have been somewhat conflicting (Kales et al. 2015).
Antidepressants may, however, increase the risk of falls (Hartikainen et al. 2007). Mood stabilizers, 
such as lamotrigine or carbamazepine, have also shown some efficacy in NPS (e.g. in anxiety and 
irritability) in AD patients, but good-quality studies on these medications are scarce (Kales et al. 
2015, Suzuki et al. 2015). Benzodiazepines are not recommended for treatment of NPS, as their 
profile of adverse effects (gait abnormalities, falls, worsening cognition, confusion) is poor, and 
they are to be left as emergency medicines, when the patient needs prompt sedation or relief of 
anxiety (Koenig et al. 2016). 
Recent guidelines suggest non-pharmacological treatments as the first-line treatment choice for 
NPS (Current care guidelines, Finland 2017). The non-pharmacological treatments comprise 




analyses and systematic reviews have explored these treatments (Olazaran et al. 2010, Brodaty et al. 
2012, Thune-Boyle et al. 2012, Kales et al. 2015) Some positive effects have been found for music 
therapy (Preuss et al. 2016), physical exercise (Thune-Boyle et al. 2012, Kales et al. 2015, Preuss et 
al. 2016), cognitive stimulation (Olazaran et al. 2010), and multicomponent interventions 
(combining cognitive stimulation with, for example, physical exercise or ADL training) for PWD 
(Olazaran et al. 2010). The meta-analysis of 23 RCTs concluded that interventions aimed at family 
caregivers can significantly alleviate NPS, with effects that are at least comparable to those of 
antipsychotic drugs (Brodaty et al. 2012). Thus, the strongest evidence base seems to be for 
behavioural interventions (analysis and modification of unwanted behaviour; family caregiver 
education) (Olazaran et al. 2010, Kales et al. 2015) and professional caregiver education (Olazaran
et al. 2010).
One of the most keenly studied non-pharmacological approaches to NPS in dementia is exercise. 
Directs effects of exercise on the brain and vascular health are discussed in detail elsewhere in this 
dissertation. It is possible that also such mechanisms as improved well-being and self-esteem and 
increased social contacts may generate symptomatic relief as a result of exercise in dementia 
patients (Thom et al. 2011).
A large body of evidence demonstrates that physical exercise among healthy older adults reduces 
depressive symptoms and anxiety and improves sleep and quality of life (Fox et al. 2007, Windle et 
al. 2010, Brindle et al. 2012, Bauman et al. 2016, Catalan-Matamoros et al. 2016) without major 
adverse effects (Catalan-Matamoros et al. 2016). The effects of exercise on depression seem to be 
fairly sustainable over time (Singh et al. 2001), and patients who are physically active are less likely 
to relapse (Babyak et al. 2000). 
A physically active lifestyle can lower the risk of NPS in PWD.  A Brazilian cross-sectional study 
categorized participants according to their type of dementia and level of physical activity (lower or 
higher). The AD patients with higher physical activity presented with fewer neuropsychiatric 
disturbances measured with the NPI. Among the other subgroups, the effects were smaller. 
However, the baseline dementia severity was not assessed, and thus, it is not possible to control the
influence of dementia severity on NPI scores (Christofolletti et al. 2011). Another cross-sectional
study performed among AD patients concluded that patients who exercised regularly were less 
likely to be depressed (Regan et al. 2005).
The results of RCTs examining the effects of exercise on NPS in dementia are more conflicting. 
Table 4 presents 19 RCTs with a study population composed of PWD, with exercise as the main 




in nursing home settings (Alessi et al. 1999, van de Winckel et al. 2004, Rolland et al. 2007, 
Williams et al. 2008, Conradsson et al. 2010, Dechamps et al. 2010, Eggermont et al. 2010, Cheng 
et al. 2014, Telenius et al. 2015, Cancela et al. 2016, Fleiner et al. 2017) and eight among 
community-dwelling patients (Miu et al. 2008, Steinberg et al. 2009, McCurry et al. 2011,
Vreugdenhil et al. 2012, Lower et al. 2014, Holthoff et al. 2015, Hoffman et al. 2016, Morris et al. 
2017). The number of participants varied from 25 to 200, half of the studies being relatively large,
with more than 100 participants (Rolland et al. 2007, Conradsson et al. 2010, Dechamps et al. 2010,
Eggermont et al. 2010, McCurry et al. 2011, Lowery et al. 2014, Telenius et al. 2015, Cancela et al. 
2016, Hoffman et al. 2016). The type of exercise in the interventions varied from yoga to indoor
cycling. The most common type was multicomponent exercise, i.e. two or more exercise types 
together in one session. In all studies, participants exercised at least twice a week, in most of the 
studies three times a week or even daily. Ten studies had an active control group with social or 
recreational activities or light exercise (Alessi et al. 1999, van de Winckel et al. 2004, Williams et 
al. 2008, Conradsson et al. 2010, Eggermont et al. 2010, Cheng et al. 2014, Telenius et al. 2015, 
Cancela et al. 2016, Fleiner et al. 2017, Morris et al. 2017).
Ten of the 19 studies found a positive effect of the exercise intervention on one or several NPS.
Depression was studied in 12 studies (Rolland et al. 2007, Dechamps et al. 2008, Miu et al. 2008, 
Williams et al. 2008, Steinberg et al. 2009, Conradsson et al. 2010, Vreugdenhil et al. 2012, Chen et 
al. 2014, Telenius et al. 2015, Cancela et al. 2016, Hoffman et al. 2016, Morris et al. 2017). Only 
one study showed beneficial effects of exercise on depression (Williams et al. 2008). The study 
included participants with depressive symptoms at baseline. Cornell Scale for Depression in 
Dementia (CSDD) scores improved in both the exercise group and the control group with regular 
conversation sessions. Thus, no difference between the study groups was detected (Williams et al. 
2008). Six larger studies (number of participants 160 to 200) observed no significant improvement 
in depressive symptoms after the exercise intervention (Rolland et al. 2007, Dechamps et al. 2008,
Conradsson et al. 2010, Telenius et al. 2015, Cancela et al. 2016, Hoffman et al. 2016).
Neuropsychiatric symptoms were explored in ten RCTs using global assessment methods (van de 
Winckel et al. 2004, Rolland et al. 2007, Dechamps et al. 2008, Steinberg et al. 2009, Lowery et al. 
2014, Holthoff et al. 2015, Telenius et al. 2015, Cancela et al. 2016, Hoffman et al. 2016, Fleiner et 
al. 2017). NPI was used in majority of the studies presented in Table 4.
Six out of ten studies found a positive effect of exercise on one or several NPS (Dechamps et al. 




al. 2017). The single NPS showing the strongest positive association with exercise appeared to be 
apathy, agitation (or aberrant motor behaviour), irritability, and appetite (Dechamps et al. 2008, 
Telenius et al. 2015, Hoffman et al. 2016, Fleiner et al. 2017). The type of exercise intervention 
producing the most beneficial effects seemed to be a combination of aerobic, strength, and balance 
training (Williams et al. 2008, Telenius et al. 2015) or exercise demanding mind-body interaction 
such as Tai Chi or yoga (Dechamps et al. 2008). Intensive training from three to seven times a week
was related to beneficial effects (Dechamps et al. 2008, Williams et al. 2008, Holthoff et al. 2015,
Hoffman et al 2016). A large French study among AD patients residing in nursing homes found no 
improvement in NPI after a 12-month intervention with multicomponent training twice a week. 
However, participants in this study were extremely frail and the mean MMSE was 8.8, indicating 
severe dementia (Rolland et al. 2007). Another good-quality study failed to show improvement in 
NPI after intervention comprising 30-minute walking sessions five times a week for 12 weeks. 
However, the trend for lower NPI after exercise intervention was positive, although the changes did
not attain significance. The researchers speculated that the unfavourable results may be related to 
poor adherence to the exercise and short duration of the intervention (Lowery et al. 2014).
Sleep as a primary outcome was explored in three studies (Alessi et al. 1999, Eggermont et al. 2010,
McCurry et al. 2011). Sleep was measured with wrist actigraphies. McCarry and co-workers 
randomized community-dwelling AD patients to walking group, light exposure group, and a
combination group (walking + light exposure). All groups improved in total wake time, especially 
those with better adherence to walking and light exposure recommendations (McCurry et al. 2011).
A smaller study among nursing home patients showed similar results after 14 weeks’ functional 
training performed five times a week. However, a short exercise study of six weeks found no effect
on night-time restlessness among PWD living in nursing homes (Eggermont et al. 2010).
Only one study examined the impact of exercise on anxiety in AD patients. Patients enrolled in the 
study had mild or moderate depression at baseline. After a 16-week intervention of walking 30 
minutes five times a week, the anxiety scores measured with the Observed Affect Scale (Lawton et 
al. 1996) showed improvement (Williams et al. 2008).
Psychotropic medication is widely used to alleviate the NPS in PWD. Many of the studies included 
in the review presented the baseline psychotropic medication, however, only one study analysed the
effects of the intervention regarding the changes in psychotropic medication. In this study, no





The summary data of RCTs are somewhat disappointing, with fairly weak and inconsistent evidence 
for beneficial effects of exercise on NPS. However, the lack of evidence is not necessarily 
indicative of a lack of efficacy. The trajectories of NPS are not easy to predict, as the symptoms
may fluctuate over time and the controls may also experience spontaneous recovery (Brodaty et al. 
2015). The NPS also differ in various dementia types and stages, and these baseline characteristics 
play an important part in predicting the subsequent course of symptoms (Brodaty et al. 2015, 
Caputo et al. 2008, Kim et al. 2003). Patients with severe behavioural disturbances may be less keen 
to participate in non-pharmacological intervention studies, and may even be excluded due to their 
challenging symptoms such as psychosis (Brodaty et al. 2012). In many studies, the baseline scores 
in neuropsychiatric assessments were relatively low, thus, there may have been a floor effect in 
reducing the NPS. However, stabilization of participants' NPS in a progressive disease may indicate 
that the exercise intervention is beneficial even without evidence of improvement. 
According to longitudinal studies, depressive symptoms tend to decrease over time, whereas apathy, 
agitation, and aberrant motor behaviour increase as dementia progresses (Aalten et al. 2005,
Brodaty et al. 2015). Different NPS, e.g. motor hyperactivity and apathy, can occur simultaneously 
in dementia, perhaps needing different clinical approaches (Gonfrier et al. 2012).  
Regular exercise seems to benefit PWD regarding the NPS. However, the most positive results so 
far are from studies where individually tailored multi-component interventions combining cognitive 
stimulation and exercise and caregiver support or education are applied (Olazaran et al. 2010, 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.5 Summary of the literature 
A growing body of evidence indicates that exercise may be a promising non-pharmacological 
intervention in the prevention and management of dementia (Ahlskog et al. 2011). Exercise 
improves brain health and decreases the risk of pathological symptoms associated with AD
(Erickson et al. 2012). The effects of exercise can be symptom-relieving or even disease-modifying,
as the exercise has direct neurobiological effects on the central nervous system and vascular health 
(Cassilhas et al. 2016).
The majority of epidemiological studies, systematic reviews, and randomized controlled trials
referred to in this literature review have found a positive association between exercise and one or 
several symptoms of dementia. Beneficial effects of exercise are shown in cognition, mobility, 
functional abilities, risk of falls, and neuropsychiatric symptoms of dementia. However, conflicting 
results and insufficient evidence are also disclosed in the studies. 
Heterogeneity in study design, selection of participants, data analyses, and methodological 
shortcomings can partly explain the inconsistency of the results in randomized controlled studies.
Many studies include patients with different types of dementia and with different levels of cognitive 
impairment. There is still a lack of evidence regarding whether patients in various types and stages 
of dementia benefit from exercise in a similar way.  In many of the studies, the participants have at 
least moderate or even severe stage of dementia.  In advanced dementia, the complex network of 
low cognition, poor physical functioning, frailty, and behavioural problems may not be overcome 
with a single-component intervention. Based on this literature review, the optimal dose and 




3. Aims of the study and research questions
The aim of this study is to examine the effects of a long-term, regular exercise intervention on
persons with Alzheimer’s disease.
Specific research questions in the individual studies are as follows:
1. What is the evidence from randomized controlled studies of the effects of exercise on 
cognition in persons with mild cognitive impairment or dementia when reviewed 
systematically? (Study 1)
2. What are the effects of a long-term, regular exercise intervention on cognition in persons 
with Alzheimer’s disease compared with controls in usual treatment examined in a 
randomized controlled trial? (Study 2)
3. How do patients with a mild or advanced stage of Alzheimer’s disease benefit from a long-
term exercise intervention in terms of physical performance and risk of falling? (Study 3)
4. Does regular exercise alleviate neuropsychiatric symptoms and postpone institutionalization 







4. Materials and methods
4.1 Study 1
Study 1 is a systematic review of randomized controlled trials examining the effects of exercise on 
cognition in participants with mild cognitive impairment (MCI) or memory disorder (dementia). 
Relevant studies were systematically searched in the electronic databases (PubMed, Cochrane,
DARE, and Ovid Nursing) using a mix of keywords related to cognition and exercise (cogniti*   OR 
demen*   OR Alzheimer*   OR memory decline OR memory disorder OR mild cognitive 
impairment) AND (physical activity OR physical exercise OR exercise OR fitness OR training OR 
aerobic OR strength OR functional training OR walk*). The original search was performed in 
January 2013 and repeated in May 2014. Some additional studies were found by hand-searching the 
reference lists of articles and the authors’ own literature databases. The search strategy yielded 1599 
articles. Duplicate articles and studies not relevant on the basis of the title or abstract were removed,
leaving 118 articles. These articles were examined in detail and 98 did not meet the inclusion 
criteria. Study protocols, studies that were not RCTs, studies that did not evaluate effects of 
physical exercise on cognition, or studies that were not conducted among persons with MCI or 
dementia were excluded. Only studies written in English were included. The first database search 
produced 20 relevant studies and the second search in 2014 produced an additional two studies
(Figure 1).
Each study included in this review was evaluated, and the following data were extracted: age of 
participants, dementia diagnosis (if mentioned), MMSE or other dementia rating score, whether the 
participant was a nursing home resident or community-dweller, inclusion and exclusion criteria, 
description of the intervention, duration and intensity of the intervention, sample size, outcome 
measures related to cognition, and intervention effect. To assess accuracy of extracted data, two 
reviewers independently extracted data from the same papers. No differences between the raters 
were detected. 
Methodological quality of the studies was evaluated by three independent researchers using a
modified rating system described in detail earlier in this dissertation. If differences of opinion 







4.2. Studies 2, 3, and 4
4.2.1 Study samples and procedures
Studies 2, 3, and 4 report the results of the Finnish Alzheimer Disease Exercise Trial (FINALEX),
which is a randomized controlled trial examining the effects of an exercise intervention conducted 
among home-dwelling participants with Alzheimer’s disease compared with controls (Pitkälä et al. 
2013). 
AD patients (n=1264) living in the cities of Helsinki, Espoo, and Vantaa and derived from the AD 
drug reimbursement register of the Social Insurance Institution of Finland were contacted by mail to
inquire about their interest in participating in the study. To be included in the above register, a 
person must be diagnosed with AD by a geriatrician or a neurologist based on the NINCDS-
ADRDA Alzheimer’s criteria (McKhann et al. 2011). The study nurses contacted those patients 
who returned the invitation letter and showed an interest in participating (n=497). Of these 
individuals, 12 had died before being contacted and 95 had moved to another city or their contact 
information was lacking or deficient. Altogether, 390 persons completed the telephone screen of 
inclusion criteria. Eighty-four persons refused to participate after receiving more information about
the study and 96 failed to meet all inclusion criteria. Two hundred and ten participants fulfilled the 
inclusion criteria and were enrolled in the study.
Inclusion criteria of the study were as follows: an established diagnosis of AD, a spouse living at 
the same address, age ≥ 65 years, no diagnosed terminal disease, and the ability to walk 
independently with or without a mobility aid. The participants were also required to meet at least 
one of the following criteria for frailty:  ≥1 fall in the past year, reduced walking speed, or 
unintentional weight loss. 
After the baseline assessments, the participants were randomized into three study groups: home-
based exercise group (HE), group-based exercise group (GE), and control group (CG) using 
computer-generated numbers received by telephone from a randomization centre. The participants 
were reassessed at 3, 6, and 12 months. The flow of participants and attrition rate are shown in 
Figure 2.
The study was designed to fulfil the 13 criteria of methodological quality described in detail earlier 










The Ethics Committee of Helsinki University Central Hospital approved the study protocol for the 
RCT. All participants and their spousal caregivers provided written, informed consent before 
participation.  In cases in which the participant’s judgement capacity was impaired (CDR>1), the 
spouse gave consent for both.
4.2.3 Data collection
A registered nurse and a physiotherapist assessed participants and their spousal caregivers four 
times (baseline, 3, 6, and 12 months). The assessors were blinded to the group allocation. 
At baseline, the demographic data and medical history were collected. The diagnoses and 
medications were confirmed from medical records. Based on the diagnosis, the Charlson co-
morbidity index score (Charlson et al. 1987) was calculated to evaluate the overall disease burden. 
Functional Independence Measure (FIM) (Pollak et al. 1996) was used to assess physical 
functioning. Walking abilities and physical fitness were assessed with a 10-metre walk test. 
Cognition was tested with the Mini-Mental State Examination (MMSE) (Fostein et al. 1975), Clock 
Drawing Test (CDT) (Morris et al. 1993), and Verbal Fluency (animal category fluency, VF) 
(Morris et al. 1989). Clinical Dementia Rating (CDR) (Hughes et al.1982) was used to assess the 
stage of dementia and global cognitive abilities. Neuropsychiatric Inventory (Cummings et al. 1997) 
and Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos et al.1988) were used to 
evaluate the neuropsychiatric symptoms. Blood pressure and weight were measured at every study 
visit.
In addition to the baseline visit, FIM, VF, and CDT were assessed at 3, 6, and 12 months, MMSE 
and CSDD at 12 months, and NPI at 6 months. The 10-metre walk test was performed at baseline 
and at 12 months. Data regarding falls (collected with a fall diary), utilization of social and health 
service, and nursing home placement were collected at 3, 6, and 12 months.
To ensure safety, a thorough medical examination by a geriatrician was performed on all 




4.2.4 Measures    
Outcome measures used in this study are all validated in the target population of older adults with 
AD (Bossers et al. 2012).
4.2.4.1 Cognitive measures
Global cognition was measured with the MMSE. It is an instrument widely used in clinical practice 
as well as in research (Tombaugh et al. 1992). The test examines cognitive functions, including
orientation, attention, recall, language, ability to follow instructions, ability to produce a meaningful 
written sentence, and visual construction. The MMSE score is the total number of correct answers,
with the maximum score being 30 points (Folstein et al. 1975).  A meta-analysis of studies 
examining the annual rate of cognitive decline in AD found an average rate of change of 3.3 points 
per year on the MMSE (Han et al. 2000). Another review found considerable variations between 
studies, ranging from 0.8 to 4.0 points per year (Behl et al. 2005). MMSE scores correlate with
those obtained from other types of cognitive screening tests such as Alzheimer’s disease assessment 
scale - cognitive subscale (ADAS-Cog) (Webster et al. 2017). Age, education, and cultural 
background, but not gender, affect the test results (Tombaugh et al. 1992). Longitudinal studies 
have shown that cognitive change in dementia patients can be examined using the MMSE 
(Tombaugh et al. 1992). The minimum clinically important difference (MCID) of the MMSE is 
estimated to be 1.4 points (Howard et al. 2011). 
Clinical Dementia Rating (CDR) is a 5-point scale used to characterize six domains of cognitive 
and functional performance in patients with Alzheimer’s disease and related dementias: memory, 
orientation, judgement and problem solving, community affairs, home and hobbies, and personal 
care. The information is obtained by interviewing the patient and the informant. Each domain is 
rated, and the overall score is calculated through an algorithm: 0 = normal, 0.5 = very mild 
dementia, 1 = mild dementia, 2 = moderate dementia, 3 = severe dementia. The rating provides a 
clinically valid measure of the stage of cognitive impairment (Hughes et al. 1992).
Verbal Fluency (VF) was measured by asking the participant to name as many animals as possible 
in one minute. VF is part of the CERAD (Consortium to Establish a Registry for Alzheimer's 
Disease), which is a neuropsychological test battery for assessment of patients with the clinical 
diagnosis of Alzheimer's disease (Morris et al. 1989). VF measures executive function as well as 
semantic memory (Henry et al. 2004).  The average score in the age group of 70-79 years in healthy 




In the Clock Drawing Test, the participant was asked to draw a clock from memory and draw the 
clock arms at a fixed time. The maximum score in the CDT is six points. The CDT is used to 
measure executive function. However, the test also requires verbal understanding, memory, and 
visuoconstructive abilities (Agrell et al. 1998). 
4.2.4.2 Functional measures
The primary outcome of this study was physical functioning measured with the Functional 
Independence Measure (FIM) (Pitkälä et al. 2013). FIM involves 18 specific tasks, grouped into 
two subscales, motor and cognitive. The tasks include activities such as mobility, walking, self-care, 
and communication. Each task is scored on a 7-point ordinal scale, ranging from a score of 1 to a 
score of 7. A higher score represents a higher level of independence. The total score for the FIM 
(the sum of the motor and cognition subscale scores) is a value between 18 and 126 (Pollak et al.
1996). In this study, the FIM assessments were based on a caregiver’s evaluation of the patient’s 
performance at home and an assessor’s evaluation during study visits. 
The 10-metre walk test was performed at baseline and at 12 months to assess the participant’s 
physical fitness and walking speed. The 10-metre walk test has shown good reliability and is
therefore recommended for use in clinical assessment of walking speed in older adults (Peters et al. 
2013).
The caregivers were asked to keep a continuous fall diary for the participants. The number of falls 
was collected at each study visit. A fall diary has been found to be the most valid method to record 
the number of falls (Hannan et al. 2010).
4.2.4.3 Neuropsychiatric measures
The Neuropsychiatric Inventory (NPI) was used to examine the neuropsychiatric symptoms of 
participants. The NPI is the recommended measure in intervention studies among dementia patients 
(Cummings et al. 1997, Kales et al. 2015). The NPI evaluates 12 neuropsychiatric disturbances 
frequently seen in dementia: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, 
irritability, euphoria, disinhibition, aberrant motor behaviour, night-time behaviour disturbances, 
and appetite and eating abnormalities. For each symptom, the frequency is multiplied by the
severity, with the summed score providing the total NPI score. The score ranges from 0 (no NPS) to 
144 (the highest number and most severe symptoms). The validity and reliability of NPI have been 
established, and the NPI has also been found to be sensitive to treatment (Cummings et al. 1997).




always abnormal. However, some researchers consider only a total NPI score greater than 11 points 
arising from at least three domains as evidence of marked neuropsychiatric symptoms (Rolland et 
al. 2007). Change of 8 or more indicates a clinically significant change (Howard et al. 2011). One 
of the weaknesses of the NPI is that it collects data only from the informant. To overcome this 
limitation, an international team of investigators has published a validated scale known as the 
Neuropsychiatric Inventory - Clinician rating scale (NPI-C), where the information is gathered not 
only from the proxy but also by clinically examining the patient (de Medeiros et al. 2010).
Depression was assessed using the Cornell Scale of Depression in Dementia (CSDD), which is the 
most widely used assessment method to measure depression in dementia. In CSDD, the information 
is obtained by interviewing the caregiver and by observing and interviewing the patient. The scale 
contains 19 items with a maximum score of 38 and a score >10 indicating depression (Alexipoulos 
et al. 1988). CSDD has a good sensitivity and specificity, and it has been validated in the dementia 
population (Alexopoulos et al. 1988, Körner et al. 2006).
4.2.4.4 Institutionalization
Data on admissions to permanent institutional care were retrieved from central registers. The 
definition of institutionalization in this study was placement in a nursing home or an intensified 
assisted living facility with 24-hour care for 3 months or longer.
4.2.5 Randomization
Patients fulfilling all inclusion criteria (n=210) were randomized after the baseline visit. The 
randomization was performed using computer-generated numbers received by telephone from a 
randomization centre. A total of 210 participants were randomized into three equal-sized (n=70) 
groups: 1) tailored home-based exercise (HE), 2) group-based exercise (GE), and 3) a control group 
(CG) continuing in community care.
4.2.6 Intervention
All participants and their spousal caregivers in both intervention groups and the control group 
received oral and written advice on nutrition and exercise by the study nurses.
Participants randomized into the home-based exercise group (HE) exercised twice a week for one 
hour over 12 months under the supervision of a physiotherapist specialized in dementia. The 
training sessions were organized at the participant’s home or in the vicinity outdoors. The training 
was tailored to meet the participant’s preferences and to address his/her needs and challenges in 




sessions consistently included elements of executive function training, dual-tasking, strength, 
balance, and endurance training as well as aerobic training. A more detailed description of the 
training is provided in Table 6. The exercise programme was goal-oriented. Intensity and degree of 
difficulty of the exercises were increased according to progress made. Co-operation with the 
spousal caregivers was intensive. During the home visits the physiotherapists were able to give 
support to the caregivers and strengthen their commitment to the study programme.
Physical exercise for the group-based exercise group (GE) was achieved in four-hour sessions in 
adult daycare centres twice a week over 12 months. Door-to-door taxi service and lunches were 
provided. Participants exercised in groups of 10 supervised by two physiotherapists specialized in 
dementia. The active exercise time/participant was approximately one hour/visit often divided into 
several shorter periods because of lunch and coffee breaks and waiting times for gym equipment.
Similar to in the HE group, the exercise programme consisted of aerobic training, endurance, 
balance, and strength training, as well as dual-tasking to improve executive functioning (Table 6).
Individual programmes and goals were also set for participants in the GE group, and regular re-
assessments (e.g. increasing the weights and repetitions in gym exercises) of the programme were 
conducted to ensure progress. However, whereas HE was tailored according to the participant’s 
needs, the GE was based more on a fixed programme. 
Because the primary outcome of the study was physical functioning, the focus of the exercise was 
on physical training. The dual-tasking exercises were rather simple and mainly performed alongside 
the physical training. 
Participants in both intervention groups continued the regular exercise even in case of 
hospitalization or respite care. If more intensive rehabilitation was needed, e.g. after hospitalization, 
it was organized as inpatient care in a rehabilitation centre. The spousal caregivers received regular
feedback from the physiotherapists and were also encouraged to share their questions or concerns.
Participants in the control group (CG) continued with the usual care provided by the Finnish health
















































































































































































































































































































































































































































































































































































































































































































































In the systematic review (Study 1), data were extracted and pooled where appropriate and possible 
(Lautenschlager et al. 2008, Lam et al. 2012), and the pooled treatment effects were estimated.
In the intervention study (Studies 2, 3, and 4), sample size was calculated based on the primary 
outcome measure FIM (Pitkala et al. 2013). A target sample size of about 210 (70 per group) was 
calculated to ensure 80% power to detect a 10-point difference in FIM measure between the 
treatment groups at two-sided =0.05. The drop-out rate was estimated to be 10%. 
The data appear as means with standard deviations or numbers with percentages.  In Studies 2 and 
4, statistical comparison between the groups at baseline was performed using analysis of variance 
(ANOVA), Kruskall-Wallis tests, and Chi-square test when appropriate. Difference in compliance 
between the HE and GE groups was tested with Mann-Whitney U-test. In all studies, 95% 
confidence intervals were calculated for main outcome measure estimates. 
In Study 2, all patients assessed at baseline and at 3 months were included in the data analyses of 
changes in cognitive function (modified intention-to-treat). Repeated measures were analysed using 
generalized estimating equation (GEE) models with the unstructured correlation structure. GEEs 
were developed as an extension of the general linear model (e.g. OLS regression analysis) to 
analyse longitudinal and other correlated data. GEE models take into account the correlation 
between repeated measurements in the same subject; models do not require complete data and can 
be fitted even when individuals do not have observations at all time-points. 
In Study 4, participants assessed at baseline and at 6 months for NPS with NPI (n=179) and 
participants assessed at baseline and at 12 months for depression with CSDD (n=149) were 
included in the analyses. When adjusting for confounding factors (age, sex, baseline CDR and 
FIM), analysis of covariance or logistic regression model was applied. In the case of violation of 
assumptions (e.g. non-normality), a bootstrap-type test was used.
In Study 3, the participants were re-grouped into mild dementia and advanced dementia. HE and 
GE intervention groups were combined and compared with the controls. The statistical comparisons 
at baseline between groups were performed with the t-test or the Mann-Whitney test and the Chi-
square test when appropriate. Mixed-effect models were used with appropriate contrast to analyse
the repeated measures. The incidence rate of falls was estimated and compared using Poisson 
regression models or negative binomial regression models when appropriate. Assumptions of over-




Effect size ("d") was calculated by using the method for paired samples: mean baseline scores 
minus mean follow-up scores, divided by the pooled baseline standard deviation. Effect size of 0.20 
is considered small, 0.50 medium, and 0.80 large; 95 percent confidence intervals (95% CIs) were 
obtained by bias-corrected bootstrapping (5000 replications). In Study 2, the effect sizes of main 
outcomes for completed cases are also provided. 







5.1 Characteristics and methodological quality of the RCTs examining the effects of exercise 
on cognition in MCI and AD patients
The 22 studies incorporated in the systematic review are described according to their characteristics, 
interventions utilized, study quality, and the effects of the interventions on various cognitive 
domains (Table 7).
Study participants were persons with MCI in eight studies and PWD in 14 studies (Table 7). The
number of participants in the studies varied from 21 (Venturelli et al. 2011) to 389 (Lam et al.
2012). Study sizes of over 100 participants were found in five studies (Stevens et al. 2006,
Lautenschlager et al. 2008, von Uffelen et al. 2008, Lam et al. 2012, Suzuki et al. 2013), only one 
of which (Stevens et al. 2006) was performed among PWD. The duration of the exercise
intervention varied from six weeks (Scherder et al. 2005, Eggermont et al. 2009, Yaguez et al. 
2011) to 52 weeks (Kwak et al. 2008, van Uffelen et al. 2008).
The exercise programmes predominantly concentrated on aerobic exercises such as walking, 
dancing, restorator or treadmill training combined with strength training, balance, and mobility
exercises. Tai Chi was used in two of the studies as a sole exercise method (Lam et al. 2012) or part 
of a multicomponent intervention (Burgener et al. 2008). The exercise programmes were designed
and supervised by physiotherapists, occupational therapists, or in some studies by the carers.
A wide range of cognitive measurements was used across the studies. The most frequently utilized 
tests were MMSE and ADAS-cog. These were used to measure global cognition in twelve studies. 
Executive functioning was examined predominantly with VF or CDT. Other tests measuring 
executive functions (such as Trail-making test, Task switching, Symbol-Digit, Stroop) were 
employed only in single studies. Attention and working memory were usually treated as separate 
domains, although they might also be considered as elements of executive functions (Diamond et al. 
2013).  In general, the cognitive measurements used in single studies were more numerous in the 
MCI studies than in the dementia studies, where only global cognition or one domain of cognition,
such as executive function or communication, was examined.    
Compliance was reported in six of the studies with MCI patients (Lautenschlager et al. 2008, van 
Uffelen et al. 2008, Baker et al. 2010, Nagamatsu et al. 2012, Suzuki et al. 2013) and in three of the 




reported compliance (adherence to exercise intervention) was generally good, varying from 71% 
(van Uffelen 2008) to 94% (Baker et al. 2010).
Of the eight studies examining the effects of exercise on cognition in MCI patients, four were 
considered to be of good methodological quality, the remaining four of moderate quality. Of the 
studies among dementia patients, none was deemed of good quality, four of moderate quality, and 
eight of poor quality (Table 7).
The most common methodological problems were absent or poor definition of the diagnosis of
dementia or MCI and low statistical power. Drop-outs were inadequately described, and intention-
to-treat analysis was infrequently used.
5.2 Effects of exercise interventions on different domains of cognition
5.2.1 Global cognition
Three out of five studies among MCI participants and five out of eight studies among dementia 
patients found a positive effect of exercise intervention on global cognition (Table 7). These studies 
used combined exercise training (mostly combining aerobic and strength training) (Lautenchlager et 
al. 2008, Kwak et al. 2008, Kemoun et al. 2010, Suzuki et al. 2013), or Tai Chi (Burgener et al. 
2008, Lam et al. 2012,), or the participants exercised daily (van de Winckel et al. 2004, Vreugdenhil 
et al. 2012).  Pooled effect size for improvement in ADAS-cog was calculated for two of the largest 
studies (Lautenchlager et al. 2008, Lam et al. 2012). The effect size was small (0.29, 95% CI 0.09-
0.48) (Table 7).
5.2.2 Executive function, attention, and working memory
Seven studies among the MCI patients examined the effects of exercise on executive function, 
attention, and/or working memory. Of these, six studies achieved results favouring the exercise 
intervention group (Table 7). High attendance in the exercise intervention (Van Uffelen et al 2008,
Baker et al. 2010), female sex (van Uffelen et al. 2008, Baker et al. 2010), and higher level of 
cognition at baseline (Scherder et al. 2005, van Uffelen et al. 2008, Baker et al. 2010, Lam et al.
2012, Nagamatsu et al. 2013, Suzuki et al. 2013) seemed to be crucial for positive results.  In the 
dementia population, the corresponding figure was four out of five studies.  No single factor could 
be detected among the positive studies. Better baseline cognition (Yaguez et al. 2011), 
multicomponent intervention (Christofoletti et al.  2008), and using music-based dance therapy as 
an exercise intervention (van de Winckel et al. 2006) were factors distinguishing these studies from 





Effects of exercise on memory domain were explored in seven MCI studies, three of which found 
beneficial effects, mostly on delayed recall (Table 7). These studies were of good methodological 
quality with a minimum training period of 24 weeks. However, in one study the positive effects 
were seen only in men with high attendance in the programme (Van Uffelen et al. 2008). None of 
the dementia studies showed positive results in the measures of memory (Table 7).
5.2.4 Communication 
Communication as a sole outcome was examined in two studies, both conducted among dementia 
patients. The results were mixed. In the smaller study with only AD patients, walking and 
conversation sessions three times a week for 40 weeks improved participants’ communication skills 
(Friedman et al. 1991).  However, the larger study with a shorter intervention and patients with AD 




Table 7. Characteristics and methodological quality of RCTs examining the effects of exercise on cognition 
in MCI and AD patients (positive findings highlighted). 
RCTs examining effects of exercise on 
cognition/ Domains of cognition examined 
 
Global Executive Attention Working Delayed  Declarative Communication 
cognition function memory recall memory 
Study population with mild cognitive impairment (MCI) 
  
Baker et al. 2010 
E: High intensity aerobic exercise, 45 – 60 
min x 4/week, 24 weeks      M: Moderate 
  + +   0 0   
Lam et al. 2012 
E: Tai Chi, 30 min x 3/week, 12 weeks 
                                                M: Moderate 
+ 0 +   0     
Lautenschlager et al. 2008 
E: Walking + strength training, 50 min x 3/ 
week, 24 weeks                              M: Good 
+ 0   0 0     
Nagamatsu et al. 2012 
E: Aerobic or resistance training, 60min x 
2/week, 26 weeks                           M: Good 
   + +   +     
Scherder et al. 2005 
E: Walking, 30 min x 3/week, 6 weeks 
                                                M: Moderate 
  +   0 0     
Suzuki et al. 2013 
E: Aerobic exercise, strength training, 
balance, dual-tasking, 90 min x 2/week, 24 
weeks                                              M: Good 
+     + +     
Van Uffelen et al. 2008/2009 
E: Aerobic exercise (walking), 60 min x 
2/week, 52 weeks                           M: Good 
0 0 +(f)   +(m)     
Varela et al. 2012 
E: Aerobic exercise, two groups with 
different exercise intensities, 30 min x 
3/week, 12 weeks                    M: Moderate 
0             
Study population with dementia 
  
Burgener et al. 2008 
E: Tai Chi 60 min x 3/ week (+ CBT + 
support group), 40 weeks.               M: Poor 
+             
Christofoletti et al. 2008 
E: Physiotherapy (+occupation therapy + 
physical education), 120 min x 5/week, or 
Physiotherapy 60 minx 3/week, 24 weeks. 
                                                        M: Poor 
0 + (MC)   0 0 0   
Cott et al. 2002 
E: Walk and talk sessions, 30 min x 5/ 
week, 16 weeks.                                         
M: Poor 
            0 
Eggermont et al. 2009 
E: Walking, 30 min x 5/week, 6 weeks 
                                                M: Moderate 
  0   0 0 0   
Friedman and Tappen 1991 
E: Walk and talk sessions, 30 min x 3/ 
week, 40 weeks                                          
M: Poor 
            + 
Kemoun et al 2010 
E: Walking, ergocycling, dancing 
60 min x 3/week, 15 weeks              M: 
Poor 
+             
Kwak et al. 2008 
E: Aerobic + strength training, 30-60 min x 
2-3/ week, 52 weeks                        M: Poor 




Table 7 continues 
Miu et al. 2008 
E: Aerobic + flexibility training, 60 min x 2/ 
week, 12 weeks                       M: Moderate 
0             
Steinberg et al. 2009 
E: aerobic, strength, balance, and flexibility 
training, Daily, 12 weeks 
                                                M: Moderate 
          0   
Stevens and Killeen 2006 
E: Strength training 30 min x 3/week, 12 
weeks                                               M: Poor 
  +           
Van de Winckel et al. 2004 
E: Dance therapy, 30 min daily, 12 weeks 
                                                        M: Poor 
+ +   0   +   
Venturelli et al. 2011 
E: Walking, 30min x 4/week, 24 weeks 
                                                M: Moderate 
0             
Vreugdenhil et al. 2012 
E: Daily home-based exercises and walking, 
16 weeks                                 M: Moderate 
+             
Yaguez et al. 2011 
E: Brain Gym®-training 120 min x 1/week, 
6 weeks                                   M: Moderate 
    + 0       
E= Description of the exercise intervention, M= Methodological quality of the study, see page 50 
0 = no difference between intervention and control groups, + = improvement, f = female, m=male, CBT= Cognitive behavioural 



















5.3 Characteristics of participants in Studies 2, 3, and 4
The mean age of the participants in the FINALEX study was 78 years, and 61% were men. 
According to the CDR scores, almost two-thirds were suffering from advanced dementia (CDR 2 or 
3), and the overall disease burden assessed with the Charlson comorbidity index was 2.7, indicating 
a relatively high number of chronic diseases. Of the participants, 96% were on Alzheimer’s 
medication and 38% on psychotropic medication (comprising antipsychotic, antidepressive, 
anxiolytic, and sleep medications). At baseline, the mean MMSE in the study sample was 18 (range 
0 to 29), mean score in Verbal fluency was 7.9 (range 0 to 21), and mean score in Clock Drawing 
Test was 2.3 (range 0 to 6). The baseline assessment of FIM showed already existing significant 
decline in functional abilities. The mean score in FIM was 89 (range 18 to 125), indicating that 
many of the participants needed assistance with several activities of daily living. The 
neuropsychiatric symptoms were rather minor at baseline. Mean score of CSDD was 4.9 (range 0 to
26), with scores ≥ 10 indicating probable depression. The baseline NPI scores were low, the mean 















Mean age, years (SD²) 77.7 (5.4) 78.3 (5.1) 78.1 (5.3) 0.82
Women, n (%) 30 (42.9) 25 (35.7) 26 (37.1) 0.66














MMSE⁴, mean (SD) 17.8 (6.6) 18.5 (6.3) 17.7 (6.2) 0.64
CDT⁵, mean (SD) 2.3 (2.0) 2.3 (2.0) 2.4 (2.1) 0.99
VF⁶, mean (SD) 8.2 (4.7) 7.9 (4.2) 7.5 (4.4) 0.60
FIM⁷ total, mean (SD) 88.9 (18.4) 90.1 (17.6) 89.1 (18) 0.92
CSDD⁸, mean (SD) 4.8 (4.7) 3.9 (3.5) 5.9 (5.7) 0.23
NPI⁹, mean (SD) 13.5 (12.6) 12.1 (9.8) 16.6(15.2) 0.33
On Alzheimer medication, n (%) 67 (95.7) 68 (97.1) 67 (95.7) 0.88
On psychotropic medication, n (%) 27(43) 20(35) 21(36) 0.61
CCI¹⁰, mean (SD) 2.6 (1.8) 2.5 (1.8) 3.0 (1.7) 0.13
10-metre walking speed in m/s, mean 
(SD)
0.77 (0.26) 0.81 (0.27) 0.82 (0.23) 0.55
¹Differences between the groups were tested by Chi-squared test for categorical variables and ANOVA or Kruskal-Wallis test for continuous, non-
normally distributed variables. ²SD: standard deviation; ³CDR: Clinical Dementia Rating (Hughes et al. 1992); ⁴MMSE: Mini-Mental State 
Examination (range 0-30) (Folstein et al. 1975); ⁵Clock Drawing Test (range 0-6) (Morris et al. 1993); ⁶Verbal Fluency (0->) (Morris et al. 1989); 
⁷FIM: Functional Independence Measure (0-126) (Pollak et al.1996); ⁸CSDD: Cornell Scale of Depression in Dementia (0-38) (Alexipoulos et al.




The three study groups were comparable in demographic factors, functional and cognitive abilities,
and neuropsychiatric symptoms at baseline. No significant differences in baseline assessments were
detected between groups (Table 8).
In Study 3, the participants were re-grouped according to their baseline CDR scores to determine 
whether the exercise intervention has different effects on patients with mild dementia and patients 
with advanced dementia.  Both intervention groups were also merged to achieve more statistical 
power; the quality and quantity of the exercise interventions in the home-based exercise group and 
the group-based exercise group were considered similar enough to allow this. Participants who 
remained in the trial until the first assessments of the intervention period were included in this sub-
analysis (n = 194). The characteristics of these new sub-groups are shown in Table 9.
Table 9. Baseline characteristics of participants in Study 3.











Men, n (%) 29 (66) 16 (73) 0.57 51 (60) 23 (53) 0.48
Home-exercise, n
(%)
23 (52) 45 (53)
Age, mean (SD²) 77 (5) 77 (6) 0.73 78 (5) 79 (5) 0.89
MMSE⁴, mean (SD) 22.9 (3.6) 22.5(4.1) 0.70 15.8 (6.5) 15.6(5.5) 0.91
FIM⁵, mean (SD) 104 (9) 102 (8) 0.37 80 (17) 80 (17) 0.38
¹Differences between the groups were tested using the t test or the Mann-Whitney test, and the Chi-square test when appropriate. ²SD: standard 
deviation; ³CDR: Clinical Dementia Rating (Hughes et al. 1992); ⁴MMSE: Mini-Mental State Examination (range 0-30) (Folstein et al. 1975); ⁵FIM: 
Functional Independence Measure (range 0-126) (Pollak et al. 1996)
Adherence was good in both intervention groups. The HE group attended 91% of the exercise 
sessions, while the GE group attended 84% of the sessions. Sixty-five HE participants (93%) and 55 




No significant change in participants’ physical fitness, measured with 10-metre walk test, was
detected. The mean change from baseline to 12 months in 10-metre walking speed was in the HE 
group -0.09 (95% CI: -0.14 to -0.03), effect size -0.28 (95% CI: -0.48 to -0.08), in the GE group -
0.12 (95% CI: -0.17 to -0.06), effect size -0.38 (95% CI: -0.60 to -0.19), and in the CG -0.16 (95% 
CI: -0.22 to -0.11), effect size -0.68 (95% CI: -0.94 to -0.42) (df=2,  x2=3.65; p = 0.16, adjusted for 
age, gender, and baseline value).
5.4 Effects of exercise intervention on cognition
Study 2 examined the effects of home-based and group-based exercise interventions on cognition 
compared with the control group.  Cognition was measured with the MMSE, Verbal Fluency test, 
and Clock Drawing test.  
MMSE was assessed at baseline and at 12 months. The scores decreased in all groups during the 12 
months; the mean change from baseline to 12 months was in the HE group -1.63 (95% CI: -2.64 to -
0.61), effect size -0.24 (95% CI: -0.40 to -0.10), in the GE group -1.23 (95% CI: -2.33 to -0.14), 
effect size -0.19 (95% CI: -0.34 to -0.06), and in the CG -1.08 (95% CI: -2.17. to 0.02), effect size -
0.60 (95% CI: -0.34 to 0.03). No difference was detected between the study groups (df=2, x2=0.60; 
p = 0.74, adjusted for age, gender, and baseline MMSE).
In the Clock Drawing Test, the mean change in HE was 0.48 (95% CI 0.058 to 0.91), effect size 
0.25 (95% CI: 0.06 to 0.48), in the GE 0.01 (95% CI: - 0.44 to 0.46), effect size 0.03 (95% CI: -0.20 
to 0.25), and in the CG - 0.21 (95% CI: - 0.67 to 0.25), effect size -0.10 (95% CI: -0.27 to 0.16) at 
12 months. No differences between the three groups were present at 12 months (df=2, x2=5.3; p = 
0.069, adjusted for age, gender, and CDR baseline). The difference between the HE group and the 
CG was significant at 12 months (p = 0.029, adjusted for age, gender, and CDR baseline), while the 
difference between the GE group and the CG was not significant (Figure 3).
Effect sizes for completed cases were 0.31 for HE, 0.07 for GE, and -0.07 for CG.
All groups deteriorated in Verbal Fluency, and the changes between the groups were not 




Figure 3. Mean changes in Clock Drawing Test and Verbal Fluency scores from baseline (adjusted 
for age, sex, and Clinical Dementia Rating) to 3, 6, and 12 months (mo).
5.5 Effects of exercise on functional abilities and falls in mild and advanced AD
Study 3 was a sub-analysis of a randomized controlled trial examining the effects of exercise in 
dementia patients. In the sub-analyses, the effects of exercise on functional abilities and falls rate in 
participants with mild or advanced AD were explored.  
Among participants with mild AD (CDR 0.5-1), the FIM scores decreased in the intervention group 
as well as in the control group. However, scores in the intervention group declined significantly 
slower (p < 0.001) than those in the control group. The mean difference between the groups was 
significant at 6 months. FIM change was -3.3 (95% CI: -1.5 to -5.2) in the intervention group and -
8.9 (95% CI: -5.2 to -12.7) in the control group (p = 0.003). The difference was even more 
pronounced at 12 months (FIM change, -2.7 [95% CI: -0.5 to -4.9] in the intervention group, -10.1




Participants with moderate to severe AD (CDR 2-3) showed similar deterioration in both study 
groups. No significant difference was detected between the groups. At 6 months, the FIM change 
was -13.3 (95% CI: -7.8 to -19) in the intervention group and -12.7 (95% CI: -9.0 to -16.3) in the 
control group (p = 0.82). At 12 months, the respective figures were -9.9 (95% CI: -7.0 to -12.7) and 
-14.6 (95% CI: -8.6 to -20.6) (p = 0.18) (Figure 4).
The participants with mild AD fell on average 1.24 times/person/year (95% CI: 0.92 to 1.62) in the 
intervention group and 1.84 times/person/year (95% CI: 1.28 to 2.52) in the control group. The 
Incidence Rate Ratio (IRR) (adjusted for age, sex and CCI) was 0.65 (95% CI: 0.42 to 1.01; p =
0.055) (Figure 5).
The exercise intervention had a significant effect on the risk of falling among participants with 
moderate or severe AD (CDR 2-3). Among participants in the intervention group, the rate of falls 
was 1.78 falls/person per year (95% CI: 1.49 to 2.12), while among those in the control group it was
3.76 falls/person per year (95% CI: 3.15 to 4.45). The IRR (adjusted for age, sex, and CCI) was 
0.47 (95% CI: 0.37 to 0.60; p < 0.001) (Figure 5).





Figure 5. Number (No) of falls during 12-month follow-up in study groups with different stage of
dementia.
5.6. Effects of exercise on neuropsychiatric symptoms in AD patients
Study 4 examined the effects of exercise intervention on NPS in AD patients in RCT. The NPS 
were measured with the CSDD and the NPI. In addition to these, the effects of intervention on 
neuropsychiatric subsyndromes such as “Hyperactivity” (agitation, aggressiveness, disinhibition, 
irritability, aberrant motor behaviour), “Mood and apathy” (depression, anxiety, euphoria, apathy, 
sleeping problems, eating problems), and “Psychosis” (hallucinations, delusions) were investigated. 
The NPI was administered at baseline and at 6 months. Complete NPI data for both time-points 
were obtained for 179 out of 210 participants. These participants were included in the analyses. 
Nearly 100% of the participants had one or several NPS throughout the study. The most frequently 
occurring single NPS was apathy, with 96% of participants suffering from at least some degree of 
this symptom during the study. 
The mean scores in NPI were rather low at baseline: in HE 13.5, in GE 12.1, and in CG 16.6. At 6 
months, no significant changes in total NPI or individual symptom scores were detected. In GE, a 
minor decrease in irritability scores was seen, -0.49 (95% CI: -0.99 to -0.54, p = 0.03). When
examining the effects of exercise on symptom sub-groups, the effect sizes were below statistical






























The CSDD was completed for 149 participants at baseline and 12 months. The changes over time
were modest: in HE 0.50 (95% CI: -0.67 to 1.54), in GE 1.35 (95% CI: 0.14 to 2.66), and in CG 
0.04 (95% CI: -1.56 to 1.40). The differences between the groups were not significant (p=0.81,
adjusted for age, sex, baseline CDR and FIM).
5.7 Effects of exercise on institutionalization of AD patients
The exercise intervention did not have effects on the rate of permanent institutionalization in AD 
patients. Thirteen participants in each of the intervention groups, and 11 participants in the control 
group were institutionalized during the study period and at one-year follow-up (p=0.79, adjusted for
age, sex, baseline CDR and FIM).
5.8 Adverse effects 
Complications measured during the 12-month intervention period included falls, fractures, and 
number of hospitalizations per patient. In fractures and hospitalizations, the differences between the 
intervention and control groups were insignificant. All serious medical events and causes of death 
were related to pre-existing co-morbidity, and none were directly or indirectly attributable to the 






The systematic review examining effectiveness of exercise on cognition in MCI and dementia 
patients suggested that exercise may have effects on global cognition, executive function, and 
attention. The eight studies performed among persons with MCI had in general more statistical
power, better methodological quality, and larger variety of cognitive domains measured than the 
studies performed among dementia patients. Methodological quality of the latter studies was poorer 
than that of the MCI studies, with all of the dementia studies rated as moderate or poor quality. 
Thus, the grade of evidence is more conflicting among PWD. 
Findings from the FINALEX study, a good-quality RCT examining the effects of exercise in AD 
patients, suggest that regular, long-term home-based exercise may have positive effects on 
executive function in community-dwelling older people with AD. The 12-month exercise 
intervention also slowed the deterioration of physical functioning in persons with mild Alzheimer’s
type dementia and reduced the rate of falls, especially among persons with advanced AD. However, 
it had no significant effect on NPS or the rate of institutionalizations.
6.1 Methodological considerations
In the studies included in the systematic review, the methodological shortcomings were mostly 
related to the small number of participants, inadequate description of the cognitive diagnosis, 
methods of randomization, insufficient reporting of methods of blinding, compliance, drop-outs,
and violations of the intention-to-treat concept. These problems exposed the studies to high risk of 
bias. Since this systematic review, several new studies examining the effects of exercise on 
cognition in dementia patients have been published. These studies, discussed in more detail in the 
literature review section, are on average of better methodological quality, some of them using a 
checklist (such as CONSORT) to ensure a sound methodology (Cancela et al. 2016, Hoffman et al. 
2016, Telenius et al. 2015, Toots et al. 2017).
Exercise programmes across the studies could often not be compared, even within the same exercise
type, with large variations occurring in frequency, duration, and intensity. However, in both MCI 
and AD study populations, intensive, multicomponent exercise including an aerobic component and 
long duration of the intervention seemed to be the key elements leading to positive results. 
Nevertheless, a clear dose-response effect could not be detected. The participants in the negative 
studies may not have attained the minimum effective dose; the optimal intensity, frequency, and 




An active control group was employed in 12 out of 22 studies. Low-intensity exercise, such as 
stretching, and social visits or conversation groups were frequently used as control activity. 
However, no significant differences in effects could be detected between the studies using an active 
or passive control group.  In many studies with a control group continuing normal care, participants 
showed an improvement over the course of the studies. This may be due to the Hawthorne effect as 
a result of engagement of the study personnel with the participants, leading to a diluted intervention 
effect. 
Large, high-quality studies are few as they are labour-intensive and expensive. While RCTs are 
considered “the gold standard”, their results may be subject to selection bias and may not be 
generalizable to other patient groups (Brodaty et al. 2012). Persons interested in participating in 
exercise studies are often more physically active also in their normal life than PWD in general, 
which can diminish the effects of the intervention (Hoffman et al. 2016). It is also noteworthy that
most of the RCTs examining the effects of non-pharmacological interventions, such as exercise, are 
conducted in nursing homes, although the largest impact on treatment might be gained in the 
community, where the majority of PWD live (Forbes et al. 2015).
The FINALEX study relied on rigorous methodology. The exclusion and inclusion criteria in the 
study were kept low to ensure a study population that represents well the general community-
dwelling AD population. The participants of the study were AD patients living with a spousal carer 
in the metropolitan area of Helsinki. They were included in the AD drug reimbursement register of 
the Social Insurance Institution of Finland, indicating they had undergone a thorough diagnostic 
procedure for probable AD. This explains the high rate (95%) of the participants being on AD 
medication. The study included participants in all stages of AD with several co-morbidities and 
signs of frailty to strengthen the generalizability of the results. However, the participants were 
motivated volunteers living with a carer, thereby not representing the whole AD population. Since 
women are more often the primary caregivers to their spouses, the study population was male 
dominant, thus differing from most of the dementia studies (Heyn et al. 2004, van Uffelen et al. 
2008). 
The control group did not receive any active intervention, instead continuing treatment as usual.




rehabilitation, if needed, during the study period. The community care of patients with memory 
disorders in Finland is in general of high quality, and this may have diluted the results of the study. 
The attrition rate of the participants was relatively low and comparable to other intervention studies 
conducted among community-dwelling AD patients (Teri et al. 2003 Suominen et al. 2015,
Hoffmann et al. 2016, Kallio et al. 2018). Attendance to the training sessions was high, enabling 
real measurements of the intervention effects. Interestingly, the participants with better cognition 
attended less sessions than those with more advanced dementia. 
The compliance was good in both intervention groups, but it was better in the HE group. Tailoring 
the exercises according to participant’s needs and preferences, and training in familiar surroundings, 
as in the HE group, might be responsible for the difference in compliance. However, in group
training, peer support was recognized to be a great asset to improving training motivation. Suttanon 
and co-workers have studied factors influencing adherence to exercise program in AD patients. The 
facilitating factors were, for instance, sense of commitment, perceived benefit, carer support, and 
skilled study personnel (Suttanon et al. 2012).  In both groups, the physiotherapists performing the 
interventions were experienced in working with persons with cognitive impairments, the spousal 
carers were supported, and carers were asked to encourage the participants to participate in exercise 
sessions. Additional support was offered to those participants and/or carers who showed signs of 
dropping out. The intervention was continued, if possible, also during short terms of hospitalization 
or respite care. Barriers to participating were kept low e.g. by offering free transportation to the
group exercise sessions.
The primary outcome of the study was physical functioning, and the training was planned 
accordingly. The major components of the exercises were aerobic and strength training, leaving less 
time for, for example, dual-tasking exercises. Training that combines motor and cognitive exercises, 
e.g. dual-task training, has been suggested to be the most beneficial in improving cognition (Law et 
al. 2014, Fritz et al. 2015). Moreover, to reduce neuropsychiatric symptoms in AD patients a 
tailored approach might be warranted. Different NPS may respond to different types of exercise, 
thus needing targeted interventions (Williams et al. 2008, Gonfrier et al, 2012).
Previous intervention studies have indicated that important components of a successful exercise 
programme for persons with memory disorders are concrete structure, familiarity with equipment, 




cognitive impairments (Teri et al. 1998). The intervention in the present study was designed to meet 
these requirements.   
The participants were not restricted in engaging in additional physical exercise during the study, 
and information regarding extra activities was not systematically collected. It is possible that the 
participants in the control group increased their physical activity during the study period. It may 
also have been the case that some participants in the intervention groups compensated for their extra 
activity over the rest of the day. This could explain why the exercise intervention failed to improve 
physical fitness (measured with 10-metre walk test) in the intervention groups. Some studies 
suggest that the total daily activity, including both structured and non-structured physical activity,
may be decisive to the health and functioning of older persons (Warburton et al. 2006). Without 
utilizing e.g. wearable activity sensors that continuously monitor physical activity it was not
possible in this study to measure the total amount of exercise performed by the participants.
6.2 Effects of exercise on cognition, physical functioning, fall rate, neuropsychiatric 
symptoms, and institutionalization in dementia  
In the systematic review, of the studies conducted among participants with MCI, five found positive 
effects on executive function or attention. This finding is in line with other reviews of the subject 
(Heyn et al. 2004, Wang et al. 2014, Cai et al. 2016). Effects on global cognition were found only in 
two of the MCI studies. This is not surprising since global cognition was measured with the MMSE, 
ADAS-cog or CDR, measures that in this population may not be informative because of the ceiling
effect.
In the dementia studies, 10 out of 14 were performed among populations with moderate or severe 
dementia, which leaves room for improvement. The most gains were achieved in global cognition 
and executive function measures. However, the small number of participants in the studies and lack 
of robust methodology weaken these results.
In line with the results of the systematic review, the cognitive effects of the long-term exercise 
intervention in the RCT were rather modest. The only statistically significant change in cognitive 
tests was seen in executive function, measured with the CDT, after 12 months of tailored home-
based exercise. In MMSE and VF, the changes between groups were insignificant. Small studies 
among community-dwelling dementia patients have yielded similar results on executive function 
(Yaguez et al. 2011, Arcoverde et al. 2014, Holthoff et al. 2015). A large, good-quality study with 




effects on global cognition, executive function, or attention (Hoffman et al. 2016). Exercise trials 
with positive changes in several cognitive domains have mostly been conducted in nursing home 
settings and the exercise rate has been three to seven times a week. (Cheng et al. 2014, Bossers et 
al. 2015, Cancela et al. 2016) (Table 1). In the present study, the frequency of the exercise sessions 
or the intensity of the training may have been too low.
Cognitive functions are complex and difficult to quantify. Improvement was not seen in Verbal 
Fluency scores, although it is widely used as a measure of executive function. However, in addition 
to semantic fluency, which is considered a component of executive functioning, VF is also a 
measure of semantic memory (Henry et al. 2004). Therefore, deficits in VF may reflect problems 
with semantic memory, and not solely executive dysfunction. Previous studies have suggested that 
exercise may improve executive function more effectively than memory function (Colcombe et al. 
2003, Smith et al. 2010). Although a strong association between the Clock drawing test and 
executive function has been established, the test results are also influenced by global cognition, 
visuospatial abilities, and semantic knowledge (Agrell et al. 1998).
Besides executive function, the intervention improved physical functioning (Pitkälä et al. 2013),
especially in the HE group. It can be speculated that the improvement in HE participants’ executive 
function was responsible for the improvement in physical function as well.  In addition to better 
compliance, the reason for the HE group’s improvements in executive function and physical 
functioning could be that the home-based, individually tailored intervention may have included 
more exercises meaningful for the participants that were performed in a familiar context, thus
activating both motor and cognitive functioning. 
It is well-established that exercise has direct positive effects on brain structure and functioning, as 
discussed more thoroughly elsewhere in this dissertation (Erickson et al 2012, Cassilhas et al. 
2016). Nevertheless, the effects of exercise on cognition in patients with AD have been found to be 
relatively modest. The brain damage may be speculated to already be rather extensive at the stage of 
clinical AD, with the protective effects of exercise coming too late. This is supported by the finding 
that effects of exercise are more evident in MCI patients and in older persons without known 
cognitive impairment (Lautenschlager et al. 2008, Erickson et al. 2011). 
In the present RCT, exercise intervention was found to have positive effects on physical functioning 




study included participants in different stages of AD, the question emerged of whether all of the
participants benefitted from the exercise intervention in a similar way. A literature search revealed 
that no previous studies had examined the effects of exercise in different stages of dementia. When 
regrouping the participants according to their stage of disease and studying these groups separately,
a clear difference was seen. All groups deteriorated in their physical functioning over the study 
course, as is expected when examining persons with progressive disease. However, patients with
better cognition and milder dementia seemed to benefit more from exercise intervention with
respect to retaining their level of physical functioning than patients with more advanced disease.  
This finding is in line with some previous studies examining the effects of exercise in persons with 
mild dementia and fairly high mean MMSE score (Miu et al. 2008, Vreugdenhil et al. 2012). 
Positive effects of exercise on executive function in participants with milder cognitive decline could
perhaps be the cause for the improvements in physical functioning. Those with mild dementia may 
still possess resources and capacity to restore their functioning, unlike those with advanced
dementia.  
To our knowledge, the present study is the first to show that a long-term exercise intervention may 
reduce the rate of falls in persons with advanced dementia. Thus far, only a few RCTs have focused 
on the effects of an exercise intervention for fall prevention specifically targeted to older people 
with dementia (Shaw et al. 2007, Suttanon et al. 2013, Zieschang et al. 2017). This is surprising 
since people with dementia have an increased risk for falls (Shaw et al. 2007) and for adverse 
outcomes when sustaining a fall (Montero-Odesso et al. 2012). Two studies have shown modest
positive results in lowering the fall rate by employing a similar multicomponent exercise 
programme as the present study, however, their study populations comprised persons with mild or 
moderate dementia (Suttanon et al. 2013, Zieschang et al. 2017). 
Improvements in muscle strength and function, balance, and mobility could be the primary causes
of the positive effects of exercise on fall rate in dementia patients, as sarcopenia, frailty, and gait 
impairments are strongly related to AD, especially to its advanced stage (Burns et al. 2010,
Sugimoto et al. 2017,). Since falls usually have a multifactorial cause and particularly people with 
dementia are prone to multiple risk factors, such as adverse drug effects and postural hypotension 
(Allan et al. 2009, McDonald et al. 2016), the best results in fall prevention could presumably be 
achieved using comprehensive assessments and tailored multifaceted interventions. 
The results regarding fall rate in the milder dementia group may have been non-significant because 




Exercise intervention did not have a significant effect on NPS or depression in AD patients in the 
present study. Neither was there any effect on the rate of institutionalization. These results are in 
line with some earlier studies where exercise intervention as a single intervention was unable to 
reduce NPS in dementia patients (Miu et al. 2008, Steinberg et al. 2009, Lowery et al. 2014).
Nevertheless, contradictory findings also exist. A large Danish RCT (n=200) found an intervention 
of moderate- to high-intensity aerobic exercise (60 minutes, thrice a week for 16 weeks) to be 
effective in reducing the NPS measured with NPI in participants with mild AD. However, the mean 
change in NPI was only -3.5 points (Hoffmann et al. 2016). It is estimated that only changes of 8 
points or more indicate a clinically meaningful change (Howard et al. 2010). The positive results 
seemed to be driven by some sub-items in NPI, mainly irritability (Hoffman et al. 2016). A
significant change in the same sub-item was also found in the present study. 
A good-quality study from Spain examined patients with moderate or severe dementia in nursing
home settings. The intervention group engaged in indoor cycling for at least 15 minutes daily over
64 months (Cancela et al. 2016). The long duration and intensity of the intervention may explain the 
positive effects on NPS.
In the present study, the NPI was administered after only six months of exercise for practical 
reasons, allowing speculation of whether the results would have been more favourable after a longer 
intervention period. The NPI scores were relatively low at baseline, thus, there was a floor effect in 
reducing the change in NPS. Furthermore, 99% of the patients were on Alzheimer’s medication, 
which may attenuate the NPS (Birks et al. 2006).
Physical activity has been reported to be effective in reducing depression in healthy older adults 
(Catalan-Matamoros et al. 2016), but this observation might not apply to older subjects with 
dementia. The negative results of the present study are supported by the finding that, among 12 
RCTs examining the effects of exercise on depression in PWD, only one found a positive 
association (Williams et al. 2008). In their study, the participants were AD patients with depressive 
symptoms at baseline. However, the control group with conversation activities improved as well. 
Furthermore, in two other studies the control group with recreational activities (Cancela et al. 2016) 
or cognitive activation (Dechamps et al. 2008) showed more improvement in depressive symptoms 
than the exercise intervention group.  
Since different NPS may respond to different interventions and since several NPS may occur 
simultaneously or in clusters, interventions may require individual tailoring. Thus far, the best 




multicomponent interventions for patients combining exercise with, for example, support, and with
educational programmes for carers (Borisovskaja et al. 2014, Kales et al. 2014).
The exercise intervention was unable to decrease the rate of permanent care placement in this study. 
Medical, social, and psychological factors leading to institutionalization of PWD may be too 
numerous and complex to be overcome with a single intervention such as exercise. Again, a more 
extensive and multifaceted approach may produce better results. 
Abundant use of psychotropic medication in the study population may have affected the overall 
results. The data of psychotropic medication use were collected at baseline, but not at post-
intervention, thus, it was not possible to determine whether the exercise intervention was effective 
in decreasing the use of these potentially harmful medications. This aspect has been only marginally 
explored previously (Barreto et al. 2015), and further studies are needed.
6.3 Strengths and limitations of the study
The systematic review was designed to answer a specific research question. It focused on the 
precise identification of participants, interventions, outcomes, and study design (PICOS). The 
flowchart of the study to demonstrate the identification and screening of the studies was presented 
according to PRISMA guidelines (Liberati et al. 2009).  A meta-analysis of the incorporated data 
was not possible due to variations in study settings, interventions, and reporting of outcome 
measures. However, a descriptive analysis of individual results across the studies was performed
and supplemented with a thorough methodological evaluation by three independent reviewers. 
The rigorous methodology was the primary strength of this randomized controlled study examining 
the effects of an exercise intervention on AD patients. The sample size was large, compliance with 
the intervention was good, and attrition rate was low. The outcome measures were valid and widely 
used in dementia studies (Bossers et al. 2012).
In addition, all participants had a confirmed diagnosis of probable AD. Many intervention studies 
conducted among dementia patients include participants with various types of dementia or fail to 
report the definite dementia diagnosis of participants (Pitkälä et al. 2013), weakening the
methodological quality and comparability with other studies. The exercise intervention in the
present study was long-term, intensive, and included several domains of exercise (aerobic, strength, 
and balance). Both intervention types (group and home-based) were also simple enough to be easily 




For the systematic review, a great effort was made to ensure that all relevant studies would be 
identified through database and hand search. However, it is possible that some studies went
unnoticed. In addition, a publication bias may exist. Lack of available homogeneous data also 
limited the possibility to combine studies for meta-analysis. 
A limitation of the secondary analyses of the RCT reported in this dissertation is that the power 
calculations were based on the primary outcome (physical performance measured with FIM) of the 
study. Moreover, the primary focus was on physical performance, which restricted the number and 
timing of cognitive and neuropsychiatric measures. Because of the cognitive and physical frailty of 
the study participants, there was an intention to avoid exhaustive study visits with numerous 
assessments.  
An additional limitation is that the study was not blinded, exposing the study to a risk of bias. In an 
exercise study it is not feasible to keep the participants and physiotherapists performing the 
intervention blinded. The outcome assessors were blinded to the group allocation, but the 
participants were often keen on sharing their experiences during the assessments, thus
compromising the blinding. However, the outcome assessors were unaware of the precise study 
questions and they were not co-investigators.  
In Study 3, the randomized study design was lost when the participants were regrouped according to 
their stage of dementia; interpretation of the results should therefore be done with caution. This
violation of methodology was, however, the only way to measure the effects of exercise during
various stages of dementia. 
Some limitations in external validity exist because the participants were motivated volunteers living 






A systematic review of RCTs examining the effects of exercise on cognition in MCI and dementia 
patients found a positive association between exercise intervention and improvements in cognition, 
especially global cognition, executive function, and attention, in participants with MCI. In studies 
among dementia populations, the results were more contradictory. Studies among MCI populations
were in general more numerous and methodologically more rigorous than studies among dementia 
patients. 
A large RCT was conducted among community-dwelling AD patients exploring the effects of a 12-
month exercise intervention on cognition, physical functioning, NPS, institutionalization, and fall
rate. 
Participants in the home-based exercise group improved in executive function measured with the 
Clock Drawing Test compared with controls receiving no active intervention.
Participants with mild dementia had significant positive changes in their physical functioning, 
measured with the FIM, after 12 months of exercise. Participants with a moderate or severe stage of 
AD fell significantly less than their peers in the control group during the 12-month follow-up.
The exercise intervention had no effects on NPS or institutionalization of AD patients.
The exercise intervention was safe, with no adverse effects related to the study activities.
Combining the results of the present study and the primary results of the FINALEX study (Pitkälä 
et al. 2013), it can be concluded that exercise shows many benefits in AD patients at all stages of 
the disease. Exercise has no major adverse effects and is cost-effective. It could be recommended as 






A growing body of evidence suggests that regular exercise may improve or slow the decline of 
functional abilities and cognition and reduce the rate of falls in PWD. However, large, rigorously 
conducted RCTs are still scarce, especially among community-dwelling PWD. Further research is 
needed to determine the optimal type, intensity, and duration of exercise as well as the optimal 
combination of various exercise domains. This kind of research could be implemented by using 
activity sensor technology or activity data from smart-phones, allowing the total amount of physical 
activity to be measured and everyday exercise routines to be monitored more accurately. 
Furthermore, the future generations of older adults as well as PWD are accustomed to using
technological devices, and this could be utilized in exercise studies by, for instance, using virtual 
training.
The effectiveness of exercise on NPS has mostly been studied in trials in which NPS is a secondary 
endpoint, as in the present study, and the participants do not suffer from significant NPS. Future 
exercise studies should focus on participants who have significant NPS in order to avoid the floor 
effect. Use of psychotropic medicine to treat NPS in PWD is abundant. Studies exploring exercise 
as a potential treatment strategy to reduce the use of psychotropic medicine are almost non-existent. 
More studies in this area are warranted, as the adverse effects of psychotropics generally outweigh 
their benefits.
Caregiver training and coaching have been shown to be effective in PWD care. Future trials could 
integrate caregiver training and exercise to examine the benefits of these treatments. 
Exercise is a symptom-relieving and perhaps even disease-modifying treatment of dementia that can 
be used together with pharmacological and other therapies. Physical exercise appeared to be safe 
even in this frail population. Tailoring the programmes to meet the needs and preferences of PWD
and employing trainers experienced in working with PWD would likely provide the most beneficial
results. Implementing regular exercise programmes into the normal care of PWD is strongly 
recommended.
Regular exercise at all stages of dementia should be part of normal, good-quality care. Its 
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Appendix 1. Mini-Mental State Examination (MMSE)
Appendix 2. Clinical Dementia Rating (CDR)
Appendix 3. Clock Drawing Test and Verbal Fluency
Appendix 4. Neuropsychiatric Inventory (NPI)
Appendix 5. Cornell Scale for Depression in Dementia (CSDD)

   Väärin Oikein
1.  Mikä vuosi nyt on?   0  1
2.  Mikä vuodenaika nyt on?   0  1
 (talvi = joulu, tammi, helmi
 kevät = maalis, huhti, touko
 kesä = kesä, heinä, elo
 syksy = syys, loka, marras; aina ± 1 vko)
3.  Monesko päivä tänään on? (± 1 pv)  0  1
4.  Mikä viikonpäivä tänään on?   0  1
5.  Mikä kuukausi nyt on?   0  1
6.  Missä maassa olemme?   0  1
7.  Missä maakunnassa olemme? 0  1
 (Myös vanhan läänijaon mukaiset
 vastaukset hyväksytään)
8.  Mikä on tämän paikkakunnan nimi?  0  1
9.  Mikä on tämä paikka jossa olemme?  0  1
 (Sairaalan/terveyskeskuksen nimi, kotiosoite)
10.  Monennessako kerroksessa olemme?  0  1
11.  Seuraavassa pyydän Teitä painamaan mieleen
 kolme sanaa. Kun olen sanonut ne, toistakaa
 perässäni. (Kaksi vaihtoehtoista sarjaa)
 PAITA – RUSKEA – VILKAS
 RUUSU – PALLO – AVAIN
 PAITA  RUUSU  0  1
 RUSKEA  tai  PALLO  0  1
 VILKAS  AVAIN  0  1
 (Merkitään ensimmäisellä kerralla muistetut sanat.
 Jos ensimmäisessä toistossa tulee virheitä, sanoja
 kerrataan, kunnes kaikki kolme sanaa on opittu.)
 Toistoja____(enintään 5 kertaa).
12.  Nyt pyydän Teitä vähentämään 100:sta 7 ja saamastan- 
 ne jäännöksestä 7 ja edelleen vähentämään 7, kunnes 
 pyydän lopettamaan.
  93......  0  1
  86......  0  1
  79......  0  1
  72......  0  1
  65......  0  1
 (Kysymys voidaan toistaa kerran, jos sitä ei heti ymmär-
 retä. Jos henkilö tekee välillä virheen, mutta jatkaa siitä
 oikein vähentäen 7 virheellisestä luvusta, tulee vääriä




Seuraavassa esitän Teille erilaisia pieniä muistiin ja älyllisiin toimintoihin liittyviä kysymyksiä ja tehtäviä:
KÄÄNNÄ
   Väärin Oikein
13.  Mitkä olivat ne kolme sanaa, jotka
 pyysin Teitä painamaan mieleenne?
 (Sanojen järjestyksellä ei ole merkitystä.)
 PAITA  RUUSU  0  1
 RUSKEA  tai  PALLO  0  1
 VILKAS  AVAIN  0  1
14.  Nyt kysyn Teiltä kahden esineen nimeä.
 a) Mikä tämä on? – näytetään rannekelloa  0  1
 b) Mikä tämä on? – näytetään lyijykynää  0  1
15.  Nyt luen Teille lauseen. Pyydän Teitä
 toistamaan sen perässäni:
 EI MITÄÄN MUTTIA EIKÄ JOSSITTELUA  0  1
 (Annetaan piste vain, jos lause on täysin oikein. 
 Lausetta ei saa toistaa.)
16.  Seuraavaksi annan Teille paperin ja 
 pyydän Teitä tekemään sille jotain.
 (Paperi asetetaan pöydälle tutkittavan eteen.)
 Ottakaa paperi vasempaan käteenne. Taittakaa
 se keskeltä kahtia ja asettakaa polvienne päälle.
 (Ohjeita ja lausetta ei saa toistaa eikä henkilöä
 saa auttaa.)
 Ottaa paperin vasempaan käteen  0  1
 Taittaa sen   0  1
 Asettaa paperin polville   0  1
17.  Näytän Teille tekstin ”SULKEKAA SILMÄNNE”.
 Pyydän Teitä lukemaan sen ääneen ja
 noudattamaan sen ohjetta.   0  1
 (Annetaan piste vain, jos sekä lukee tekstin
 että sulkee silmänsä.)
18.  Kirjoittakaa kokonainen lyhyt lause 
 mielenne mukaan. (ks. seuraava sivu) 0  1
 (Yksi piste, jos lause on ymmärrettävä ja 
 siinä on ainakin subjekti ja predikaatti. 
 Kirjoitusvirheet eivät vaikuta.)
19.  Voisitteko piirtää tämän kuvion alapuolelle
 samanlaisen kuvion. (ks. seuraava sivu) 0  1
 (Annetaan piste, jos kaikki sivut ja kulmat ovat tallella
 ja leikkauspinta on nelikulmainen.)
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kaan ja usein paikkaan.
Merkittäviä vaikeuksia 
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Tutkittavan nimi ____________________________________________ Nro ________ Päiväys ___________ 





























Seulontakysymys: Onko potilaalla uskomuksia, joiden tiedätte olevan todellisuudenvastaisia? Väittääkö  
hän esimerkiksi, että ihmiset yrittävät vahingoittaa häntä tai varastaa häneltä? Onko potilas sanonut, että 
perheenjäsenet eivät ole keitä sanovat olevansa tai että koti ei ole heidän kotinsa? En tarkoita pelkästään 
epäluuloisuutta, vaan sitä, että potilas on todella vakuuttunut siitä, että hänelle tapahtuu tällaista.
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset    Ei  Kyllä
1. Uskooko potilas olevansa vaarassa tai että muut aikovat vahingoittaa häntä?
2. Uskooko potilas, että muut varastavat häneltä?
3. Uskooko potilas, että hänen puolisonsa on uskoton?
4. Uskooko potilas, että hänen kodissaan asuu kutsumattomia vieraita?
5. Uskooko potilas, että hänen puolisonsa tai muut ihmiset eivät ole keitä 
 sanovat olevansa?
6. Uskooko potilas, että hänen asuntonsa ei ole hänen kotinsa?
7. Uskooko potilas, että perheenjäsenet aikovat hylätä hänet?
8. Uskooko potilas, että televisiossa ja lehdissä esiintyvät ihmiset ovat todella 
 hänen kotonaan? (Yrittääkö hön puhua heille tai olla muulla tavoin vuoro-
 vaikutuksessa heidän kanssaan?)
9. Onko potilaalla muita epätavallisia luuloja, joista en ole kysynyt?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi harhaluulojen yleisyys ja 
vaikeusaste ja määritä niistä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – vähintään kerran päivässä.
Vaikeusaste: 1.  Lievä – potilaalla on harhaluuloja, mutta ne ovat harmittomia eivätkä näytä   
    juuri vaivaavan potilasta.
   2.  Melko vaikea – harhaluulot ovat häiritseviä ja ahdistavia.
   3.  Vaikea – harhaluulot ovat hyvin häiritseviä ja merkittävä käyttäytymishäiriöitä  
    aiheuttava tekijä.
Stressi: Kuinka häiritseviä harhaluulot ovat mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon






Seulontakysymys: Onko potilaalla aistiharhoja, esimerkiksi näkö- tai kuuloharhoja? Vaikuttaako siltä, että 
hän näkee, kuulee tai kokee olemattomia asioita? Tämä kysymys ei viittaa pelkästään vääriin uskomuksiin, 
kuten siihen, että joku, joka on kuollut, olisikin yhä elossa, vaan siihen, että potilaalla todella on poikkeavia 
kuulo- ja näköaistimuksia.
 Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
 Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset    Ei  Kyllä
1. Sanooko potilas kuulevansa ääniä tai käyttäytyykö hän ikään kuin kuulisi ääniä?
2. Puhuuko potilas olemattomille henkilöille?
3. Sanooko potilas näkevänsä asioita, joita muut eivät näe tai käyttäytyykö hän
 ikään kuin näkisi jotain, mitä muut eivät näe (ihmisiä, eläimiä, valoja jne.)?
4. Sanooko potilas haistavansa hajuja, joita muut eivät haista?
5. Sanooko potilas tuntevansa ihollaan jotain tai vaikuttaako hän muuten siltä 
 kuin tuntisi jonkin ryömivän ihollaan tai koskettavan häntä?
6. Kuvaileeko potilas makuaistimuksia, joiden alkuperää ei tiedetä?
7. Kuvaileeko potilas muita epätavallisia aistikokemuksia?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi aistiharhojen yleisyys ja 
vaikeusaste ja määritä niistä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
  2 Usein – noin kerran viikossa.
  3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
  4 Erittäin usein – vähintään kerran päivässä.
Vaikeusaste: 1.  Lievä – potilaalla on aistiharhoja, mutta ne ovat harmittomia eivätkä näytä   
   juuri vaivaavan potilasta.
  2.  Melko vaikea – aistiharhat ovat häiritseviä ja ahdistavia.
  3.  Vaikea – aistiharhat ovat hyvin häiritseviä ja merkittävä käyttäytymishäiriöitä  
   aiheuttava tekijä.
Stressi: Kuinka häiritseviä aistiharhat ovat mielestänne?
  0  Ei lainkaan
  1  Hyvin vähän
  2  Jonkin verran
  3  Melko paljon
  4  Paljon






Seulontakysymys: Onko potilaalla kausia, jolloin hän kieltäytyy yhteistyöstä tai ei ota vastaan apua? 
Onko häntä vaikea käsitellä?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Hermostuuko potilas ihmisiin, jotka yrittävät huolehtia hänestä tai vastuste-
 leeko hän esimerkiksi kylvettämistä tai vaatteiden vaihtamista?
2. Onko potilas itsepäinen ja vaatiiko hän, että asiat tehdään niin kuin hän haluaa?
3. Onko potilas yhteistyöhaluton, vastustaako hän tarjottua apua?
4. Käyttäytyykö potilas muulla tavoin siten, että häntä on vaikea käsitellä?
5. Huutaako tai kiroileeko potilas vihaisesti?
6. Paiskooko potilas ovia, potkiiko huonekaluja tai heitteleekö hän tavaroita?
7. Yrittääkö potilas lyödä tai vahingoittaa muita?
8. Käyttäytyykö potilas muuten aggressiivisesti tai kiihtyneesti?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi levottomuuden/aggressiivi-
suuden yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – vähintään kerran päivässä.
Vaikeusaste: 1.  Lievä – potilaan käyttäytyminen on häiritsevää, mutta hallittavissa    
    rauhoittelulla ja ohjailulla.
   2.  Melko vaikea – käyttäytyminen on häiritsevää ja sitä on vaikea ohjailla ja hallita.
   3.  Vaikea – levottomuus/aggressiivisuus on hyvin häiritsevää ja aiheuttaa paljon  
    vaikeuksia. Potilas saattaa vahingoittaa itseään.
Stressi: Kuinka häiritsevää levottomuus/aggressiivisuus on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon






Seulontakysymys: Vaikuttaako potilas surulliselta tai masentuneelta? Sanooko hän olevansa 
surullinen tai masentunut?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Esiintyykö potilaalla ajoittain itkuisuutta tai nyyhkimistä, joka viittaa 
 surumielisyyteen?
2. Puhuuko tai käyttäytyykö potilas surullisen tai alakuloisen oloisesti?
3. Vähätteleekö potilas itseään tai sanooko hän olevansa epäonnistunut?
4. Sanooko potilas olevansa paha ihminen tai ansaitsevansa rangaistuksen?
5. Vaikuttaako potilas lannistuneelta tai sanooko hän ettei hänellä ole tulevaisuutta?
6. Sanooko potilas olevansa taakaksi perheelle tai että perheellä olisi parempi 
 ilman häntä?
7. Ilmaiseeko potilas toivovansa kuolemaa tai puhuuko hän itsemurhasta?
8. Näkyykö potilaassa muita masennuksen tai surullisuuden merkkejä?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi masentuneisuuden/ala-
kuloisuuden yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – masennus ahdistaa potilasta, mutta lievittyy tavallisesti rauhoittelulla ja  
    ohjailulla.
   2.  Melko vaikea – masennus ahdistaa potilasta, hän ilmaisee masennusoireet   
    spontaanisti ja niitä on vaikea lievittää.
   3.  Vaikea – masennus on hyvin ahdistavaa ja aiheuttaa potilaalle paljon kärsimystä.
Stressi: Kuinka häiritsevää masentuneisuus/alakuloisuus on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon






Seulontakysymys: Onko potilas hyvin hermostunut, huolestunut tai peloissaan ilman selvää syytä? 
Vaikuttaako hän hyvin jännittyneeltä tai rauhattomalta? Pelkääkö potilas jäädä yksin?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Sanooko potilas, että tapahtumat, joita on suunniteltu, huolestuttavat häntä?
2. Onko potilaalla ajoittain hutera olo tai onko hän kykenemätön rentoutumaan 
 ja ylijännittynyt?
3. Onko potilaalla ajoittain (tai valittaako hän) hengenahdistusta, hengenhaukko-
 mista tai huokaileeko hän ilman muuta selvää syytä kuin hermostuneisuus?
4. Valittaako potilas, että ”hänellä on perhosia vatsassa” tai että hänen sydämensä 
 hakkaa tai tykyttää hermostuksesta? (Potilaan sairauden tila ei selitä oireita.)
5. Välttääkö potilas paikkoja tai tilanteita, jotka lisäävät hermostuneisuutta, kuten 
 autolla kulkemista, ystävien tapaamista tai väenpaljoutta?
6. Hermostuuko tai hätääntyykö potilas, jos hän joutuu eroon Teistä (hoitajastaan)? 
 Takertuuko hän Teihin, jotta ei joutuisi Teistä eroon?
7. Osoittaako potilas muita ahdistuneisuuden merkkejä?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi ahdistuneisuuden yleisyys ja 
vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – vähintään kerran päivässä.
Vaikeusaste: 1.  Lievä – ahdistuneisuus vaivaa potilasta, mutta lievittyy tavallisesti rauhoittelulla ja  
    ohjailulla.
   2.  Melko vaikea – ahdistuneisuus vaivaa potilasta, hän ilmaisee ahdistusoireet   
    spontaanisti ja niitä on vaikea lievittää.
   3.  Vaikea – ahdistuneisuus on hyvin voimakasta ja aiheuttaa potilaalle paljon   
    kärsimystä.
Stressi: Kuinka häiritsevää ahdistuneisuus on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon







EA (Ei arvioitavissa)Kohonnut mieliala/epäasianmukainen iloisuus
Seulontakysymys: Vaikuttaako potilas liian iloiselta tai onnelliselta ilman syytä? En tarkoita normaalia 
iloisuutta, joka johtuu ystävien tapaamisesta, lahjojen saamisesta tai yhdessäolosta perheen kanssa. Kysyn 
sitä, onko potilas jatkuvasti poikkeavan hyväntuulinen tai onko hän huvittunut asioista, joita muut eivät pidä 
hauskoina?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Vaikuttaako potilas liian tyytyväiseltä tai onnelliselta verrattuna siihen, millainen 
 hän normaalisti on?
2. Nauraako potilas asioille tai onko hän huvittunut asioista, joita muut eivät pidä 
 hauskoina?
3. Onko potilaalla lapsellinen huumorintaju ja taipumus kikattaa tai nauraa 
 sopimattomissa tilanteissa (esim.toisen vahingolle)?
4. Kertooko potilas vitsejä tai esittääkö hän huomautuksia, jotka ovat hauskoja 
 vain hänestä itsestään?
5. Tekeekö potilas lapsellisia kepposia, esim. nipistelee toisia tai leikkii hippaa 
 huvin vuoksi?
6. Kerskaileeko potilas tai väittääkö hän omaavansa enemmän kykyjä tai 
 varallisuutta kuin hänellä todellisuudessa on?
7. Vaikuttaako potilas muulla tavoin liian tyytyväiseltä tai onnelliselta?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi kohonneen mielialan/epäasian-
mukaisen iloisuuden yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – ystävät ja perheenjäsenet huomaavat kohonneen mielialan, mutta se ei  
    häiritse.
   2.  Melko vaikea – mielialan kohoaminen on selvästi epänormaalia.
   3.  Vaikea – mielialan kohoaminen on hyvin silmäänpistävää; potilas on 
    euforinen ja pitää miltei kaikkia asioita hauskoina.
Stressi: Kuinka häiritsevää mielialan kohoaminen/epäasianmukainen iloisuus on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon





Seulontakysymys: Onko potilas menettänyt kiinnostuksensa siihen, mitä hänen ympärillään tapahtuu? 
Onko hän menettänyt kiinnostuksensa asioiden tekemiseen tai puuttuuko häneltä motivaatio ryhtyä 
tekemään uusia asioita? Onko häntä aiempaa vaikeampi saada osallistumaan keskusteluun tai askareisiin? 
Onko potilas haluton tai välinpitämätön?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Onko potilaan aloitekyky heikentynyt tai vaikuttaako hän passiivisemmalta?
2. Aloittaako potilas keskustelun entistä harvemmin?
3. Osoittaako potilas vähemmän hellyttä tai tunteitaan kuin tavallisesti?
4. Osallistuuko potilas aiempaa vähemmän kotitöihin?
5. Näyttääkö potilas olevan aiempaa vähemmän kiinnostunut toisten tekemisistä 
 tai suunnitelmista?
6. Onko potilas menettänyt kiinnostuksensa ystäviä ja perheenjäseniä kohtaan?
7. Eikö potilas enää jaksa innostua häntä yleensä kiinnostavista asioista yhtä 
 paljon kuin aiemmin?
8. Osoittaako potilas muulla tavoin ettei hän välitä ryhtyä mihinkään uuteen?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi apatian/välinpitämättömyyden 
yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – apatia on havaittavaa, mutta ei juuri haittaa päivittäistä elämää; poikkeaa  
    vain lievästi potilaan normaalista käyttäytymisestä; potilas suostuu, jos hänelle  
    ehdotetaan toimintaa.
   2.  Melko vaikea – apatia on hyvin selvää; hoitaja saattaa onnistua voittamaan sen  
    suostuttelemalla ja rohkaisemalla; potilas reagoi spontaanisti vain merkittäviin  
    tapahtumiin, kuten sukulaisten tai perheenjäsenten vierailuun.
   3.  Vaikea – apatia on hyvin selvää, eikä potilas yleensä reagoi rohkaisuun tai siihen,  
    mitä hänen ympärillään tapahtuu.
Stressi: Kuinka häiritsevää apatia/välinpitämättömyys on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon





Seulontakysymys: Näyttääkö potilas toimivan hetken mielijohteesta ajattelematta ensin? Tekeekö tai 
sanooko hän asioita, joita ei yleensä tehdä tai sanota julkisesti? Tekeekö hän asioita, jotka ovat hämmentäviä 
Teille tai muille?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Käyttäytyykö potilas hetken mielijohteesta ajattelematta seurauksia?
2. Puhuuko potilas ventovieraille ihmisille ikään kuin tuntisi heidät?
3. Sanooko potilas ihmisille tahdittomia tai loukkaavia asioita?
4. Puhuuko potilas karkeasti tai esittääkö hän seksuaalisia huomautuksia, 
 mitä hän ei normaalisti tekisi?
5. Puhuuko potilas avoimesti hyvin henkilökohtaisista tai yksityisluontoisista 
 asioista, joita ei yleensä kerrota muille?
6. Ottaako potilas vapauksia, kosketteleeko tai halaileeko hän ihmisiä tavalla, 
 joka ei ole hänelle ominainen?
7. Osoittaako potilas muita merkkejä siitä, ettei hän hallitse mielijohteitaan?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi estottomuuden yleisyys ja 
vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – estottomuus on havaittavaa, mutta siihen voidaan yleensä vaikuttaa  
    ohjailulla.
   2.  Melko vaikea – estottomuus on hyvin selvää ja hoitajan on vaikea vaikuttaa siihen.
   3.  Vaikea – hoitaja ei yleensä pysty mitenkään vaikuttamaan estottomuuteen ja se on  
    kiusallista ja sosiaalisesti haittaavaa.
Stressi: Kuinka häiritsevää estottomuus on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon




EA (Ei arvioitavissa)Ärtyisyys/mielialan vaihtelu
Seulontakysymys: Ärtyykö tai häiriintyykö potilas helposti? Vaihteleeko hänen mielialansa herkästi? 
Onko hän poikkeavan kärsimätön? Tällä ei tarkoiteta muistin tai toimintakyvyn heikkenemisestä johtuvaa 
turhautumista, vaan sitä, onko potilas poikkeavan ärtyisä, kärsimätön tai tunteiltaan ailahteleva verrattuna 
siihen, millainen hän yleensä on?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1. Onko potilas pahantuulinen, menettääkö hän helposti malttinsa pikkuasioista?
2. Vaihteleeko potilaan mieliala nopeasti niin, että hän on yhtenä hetkenä 
 tyytyväinen ja seuraavassa hetkessä vihainen?
3. Onko potilaalla äkillisiä kiukunpurkauksia?
4. Onko potilas kärsimätön, onko hänen vaikea kestää viivytyksiä tai odottaa 
 suunniteltujen asioiden tapahtumista?
5. Onko potilas kärttyisä ja ärtynyt?
6. Onko potilas riidanhaluinen ja onko hänen kanssaan vaikea tulla toimeen?
7. Osoittaako potilas muita ärtyisyyden merkkejä?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi ärtyisyyden/mielialan vaihtelun 
yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – ärtyisyys/mielialan vaihtelu on havaittavaa, mutta niihin voidaan yleensä  
    vaikuttaa rauhoittelulla ja ohjailulla.
   2.  Melko vaikea – ärtyisyys/mielialan vaihtelu on hyvin selvää ja hoitajan on vaikea  
    vaikuttaa niihin.
   3.  Vaikea – ärtyisyys/mielialan vaihtelu on hyvin selvää  eikä hoitaja yleensä pysty  
    vaikuttamaan siihen. Potilaalle aiheutuu paljon kärsimystä.
Stressi: Kuinka häiritsevää ärtyisyys/mielialan vaihtelu on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon




EA (Ei arvioitavissa)Poikkeava motorinen käyttäytyminen
Seulontakysymys: Käveleekö potilas edestakaisin toistaen samoja asioita, esimerkiksi availlen kaappeja 
tai laatikoita, hypisteleekö hän esineitä tai kiertääkö esim. lankoja tai naruja kerälle?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1.  Käveleekö potilas ympäri asuntoa ilmaan selvää tarkoitusta?
2. Penkooko potilas paikkoja availlen ja tyhjentäen laatikoita tai kaappeja?
3. Pukeeko ja riisuuko potilas vaatteitaan toistuvasti?
4. Onko potilaalla tapoja tai toimintoja, joita hän toistaa toistamastaan päästyään?
5. Tekeekö potilas toistuvasti tiettyjä asioita, kuten sormeilee nappeja, hypistelee 
 esineitä, kiertää naruja kerälle tms?
6. Liikehtiikö potilas hermostuneesti, onko hänen vaikea istua aloillaan, 
 heilutteleeko hän jalkojaan tai rummuttaako hän sormillaan?
7. Toistaako potilas jotain muita toimintoja yhä uudestaan?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi poikkeavan motorisen käyttäy-
tymisen yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – poikkeava motorinen käyttäytyminen on havaittavaa, mutta ei juuri 
    häiritse päivittäistä elämää.
   2.  Melko vaikea – poikkeava motorinen käyttäytyminen on hyvin selvää, mutta 
    hoitaja pystyy lopettamaan sen.
   3.  Vaikea – poikkeava motorinen käyttäytyminen on hyvin selvää, hoitaja ei 
    yleensä pysty vaikuttamaan siihen ja se aiheuttaa potilaalle suurta kärsimystä.
Stressi: Kuinka häiritsevää poikkeava motorinen käyttäytyminen on mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon




EA (Ei arvioitavissa)Unen häiriöt
Seulontakysymys: Onko potilaalla univaikeuksia? Onko hän hereillä öisin? Kuljeskeleeko hän yöllä, 
pukeutuuko tai häiritseekö hän muuten muiden unta? (Pelkkiä satunnaisia wc-käyntejä ei pidetä unen 
häiriöinä, jos potilas nukahtaa pian käynnin jälkeen uudelleen.)
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1.  Onko potilaalla vaikeuksia nukahtaa?
2. Nouseeko potilas ylös yön aikana (pelkkiä satunnaisia wc-käyntejä ei lasketa, 
 jos hän nukahtaa heti uudelleen)?
3. Kuljeskeleeko potilas, käveleekö hän edestakaisin tai ryhtyykö hän epäasiallisiin 
 toimiin yöllä?
4. Herättääkö potilas Teidät yön aikana?
5. Herääkö potilas yöllä pukeutuen ja suunnitellen ulosmenoa ajatellen, että on 
 aamu ja aika aloittaa päivä?
6. Herääkö potilas liian aikaisin aamulla (aikaisemmin kuin hänellä oli tapana)?
7. Nukkuuko potilas liikaa päivällä?
8. Onko potilaalla muita yöllisiä häiriintyneeseen uneen liittyviä toimintoja tai 
 yönaikaista epäasiallista käyttäytymistä, jotka koette häiritseviksi ja joita ei ole 
 kysytty edellä?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi unen häiriöiden yleisyys ja 
vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka yö.
   4 Erittäin usein –käytännöllisesti katsoen jatkuvasti.
Vaikeusaste: 1.  Lievä – unen häiriöt ovat havaittavia, mutta eivät ole erityisen häiritseviä.
   2.  Melko vaikea – unen häiriöt ovat hyvin selviä ja ne häiritsevät hoitajan ja potilaan  
    nukkumista; potilaalla voi olla useamman kuin yhdentyyppisiä unen häiriöitä.
   3.  Vaikea – potilaalla on useita erilaisia unen häiriöitä tai yöaikaisia käytösoireita;  
    potilas on ahdistunut yöllä ja myös hoitajan uni häiriintyy merkittävästi.
Stressi: Kuinka häiritseviä unen häiriöt ovat mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon




EA (Ei arvioitavissa)Ruokahalun ja syömisen häiriöt
Seulontakysymys: Onko potilaan ruokahalussa, painossa tai ruokailutottumuksissa tapahtunut muutoksia? 
Tätä kysymystä ei arvioida (merkitse EA), jos potilas on vuodepotilaana ja muiden syötettävänä. 
Onko mieltymyksissä eri ruokiin ilmennyt mitään muutoksia?
  Ei, siirry seuraavaan seulontakysymykseen seuraavalle sivulle.
  Kyllä, siirry lisäkysymyksiin.
Lisäkysymykset     Ei  Kyllä
1.  Onko potilas menettänyt ruokahalunsa?
2. Onko potilaan ruokahalu lisääntynyt?
3. Onko potilaan paino pudonnut?
4. Onko potilaan paino noussut?
5. Onko potilaan ruokailutavat muuttuneet, ahtaako potilas liikaa ruokaa 
 suuhunsa kerralla?
6. Onko potilaan ruokavaliossa tapahtunut muutosta, syökö hän liikaa makeisia 
 tai joitain muita ruoka-aineita/ruokalajeja?
7. Syökö potilas aina samantyyppistä ruokaa tai aina tarkalleen samassa 
 järjestyksessä?
8. Onko potilaalla ilmennyt mitään muita muutoksia ruokahalussa tai syömisessä?
Jos seulontakysymyksen vastaus on lisäkysymysten jälkeenkin KYLLÄ, arvioi ruokahalun ja syömisen häiriöiden 
yleisyys ja vaikeusaste ja määritä siitä hoitajalle aiheutuva psyykkinen stressi.
Yleisyys: 1 Joskus – harvemmin kuin kerran viikossa.
   2 Usein – noin kerran viikossa.
   3 Hyvin usein – useita kertoja viikossa, muttei joka päivä.
   4 Erittäin usein – vähintään kerran päivässä.
Vaikeusaste: 1.  Lievä – ruokahalussa ja syömisessä on muutoksia, mutta eivät ole johtaneet 
    painon muutoksiin eivätkä ole häiritseviä.
   2.  Melko vaikea – muutokset ruokahalussa ja syömisessä ovat selviä ja ne aiheuttavat  
    pieniä painon vaihteluja.
   3.  Vaikea – ruokahalussa ja syömisessä on suuria muutoksia, ne aiheuttavat painon  
    vaihtelua ja ovat kiusallisia potilaalle tai häiritsevät häntä muuten.
Stressi: Kuinka häiritseviä unen häiriöt ovat mielestänne?
   0  Ei lainkaan
   1  Hyvin vähän
   2  Jonkin verran
   3  Melko paljon
   4  Paljon






Osio     EA  Ei esiinny  Yleisyys  Vaikeus  Y & V  Stressi
Neuropsykiatriset oireet
A. Harhaluulot   X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
B. Aistiharhat    X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
C. Levottomuus ja aggressiivisuus X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
D. Masentuneisuus ja alakuloisuus X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
E. Ahdistuneisuus   X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
F. Kohonnut mieliala/
 epäasianmukainen iloisuus X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
G. Apatia/välinpitämättömyys X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
H. Estottomuus   X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
I. Ärtyisyys/mielialan vaihtelu X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
J. Poikkeava motorinen käyttäytyminen X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
Yhteensä       _______ _______
Neurovegetatiiviset muutokset
K. Unen häiriöt   X 0 1  2  3  4 1  2  3 _______ 1 2 3 4 5
























4. Sanoo olevansa paha ihminen







F. Kohonnut mieliala   K  E  EA
1. Liian tyytyväinen, onnellinen
2. Epätavallinen huumorintaju
3. Nauraa sopimattomasti
4. Kertoo tylsiä vitsejä
5. Tekee lapsellisia kepposia
6. Kerskaileva






Ohje: Lue haastattelua koskeva ohje ennen kysymysten esittämistä. Merkitse vastaukset tälle lomakkeelle 
ennen kuin arvioit oireiden yleisyyttä, vaikeusastetta tai niistä aiheutunutta stressiä. 
K = oire esiintyy potilaalla, E = oiretta ei esiinny, EA = ei arvioitavissa.
A. Harhaluulot  K  E  EA
1. Uskoo olevansa vaarassa
2. Uskoo häneltä varastettavan
3. Uskoo puolison olevan uskoton
4. Kutsumattomat vieraat
5. Ihmiset ovat vaihtuneet
6. Asunto ei ole koti
7. Uskoo tulevansa hylätyksi





C. Levottomuus/aggressiivisuus K  E  EA




4. Vaikea käsitellä 
5. Huutaa tai kiroilee






E. Ahdistuneisuus K  E  EA
1. Huolissaan tulevasta
2. Kyvytön rentoutumaan
3. Huokaileva, haukkoo henkeään



















J. Poikkeava motorinen 
käyttäytyminen   K   E  EA
1. Kävelee ympäriinsä
2. Penkoo paikkoja









L. Ruokahalun ja syömisen 












G. Apatia  K  E  EA
1. Passiivinen
2. Ei aloita keskustelua
3. Ei osoita tunteitaan
4. Ei osallistu kotitöihin
5. Toiset ihmiset eivät kiinnosta
6. Perheenjäsenet ovat yhdentekeviä
7. Ei kiinnostu asioista kuten aiemmin




I. Ärtyneisyys K  E  EA
1. Menettää malttinsa









K. Unen häiriöt K  E  EA
1. Nukahtamisvaikeuksia




6. Herää liian aikaisin aamulla
7. Nukkuu paljon päivällä






Ohje: Lue haastattelua koskeva ohje ennen kysymysten esittämistä. Merkitse vastaukset tälle lomakkeelle 
ennen kuin arvioit oireiden yleisyyttä, vaikeusastetta tai niistä aiheutunutta stressiä. 





Pisteet yhteensä:______________________________ Pisteytys:  a     ei voida arvioida  0     ei esiinny
     1     lievä tai satunnainen  2     vakava
Pisteytyksen tulee pohjautua oireisiin ja löydöksiin, jotka ovat esiintyneet haastattelua edeltäneen viikon aikana. 
Pisteytystä ei tehdä niistä oireista, jotka johtuvat fyysisestä kyvyttömyydestä tai sairaudesta.
Cornellin masennusasteikko 
– dementiaoireisten muistisairaiden depression mittari
A   Mielialaan liittyvät oireet
1. Ahdistuneisuus  a  0  1  2
 vaikuttaa ahdistuneelta, hautoo asioita, huolestunut
2. Surullisuus  a  0  1  2
 vaikuttaa surulliselta, surullinen ääni, itkuinen
3. Ei reagoi miellyttäviin tapahtumiin  a  0  1  2
4. Ärtyisyys a  0  1  2
B   Käyttäytymisen oireet
5. Levottomuus a  0  1  2
 vaikuttaa kiihtyneeltä, vääntelee käsiään, repii hiuksiaan
6. Hidastuminen a  0  1  2
 hitaat liikkeet, hidas puhe, hitaat reaktiot
7. Moninaisten ruumiillisten oireiden valittaminen a  0  1  2
 (pisteytys 0, jos vain vatsavaivoja)
8. Mielenkiinnon menetys  a  0  1  2
 osallistuu vähemmän tavanomaisiin toimintoihinsa
 (pisteytetään vain, jos muutos tapahtunut alle kuukauden aikana)
C  Ruumiilliset oireet
9. Ruokahaluttomuus a  0  1  2
 syö tavallista vähemmän
10. Laihtuminen  a  0  1  2
  (pisteytys 2, jos paino pudonnut yli 2 kg kuukauden aikana)
11. Energian puute  a  0  1  2
  uupuu helposti, ei jaksa ylläpitää aktiviteetteja
  (pisteytetään vain, jos muutos tapahtunut alle kuukauden aikana)
D  Vuorokauden rytmiin liittyvät oireet
12. Mielialaoireet pahempia aamuisin  a  0  1  2
13. Nukahtaa myöhemmin kuin tavallisesti  a  0  1  2
14. Heräilee tavallista useammin yön aikana  a  0  1  2
15. Herää aikaisemmin kuin tavallisesti  a  0  1  2
E  Vääristyneet mielikuvat
16. Itsetuhoisuus  a  0  1  2
  ei koe elämäänsä elämisen arvoiseksi, itsemurha-ajatuksia tai itsemurhayritys
17. Itsetunnon menetys  a  0  1  2
  moitiskelee itseään, huono omanarvontunne, epäonnistumisen tunteita
18. Pessimismi  a  0  1  2
  odottaa pahinta
19. Masentunutta mielialaa ilmaisevat harhaluulot  a  0  1  2
Appendix 5.
